Computational Analysis of RNAi Screening Data to Identify Host Factors Involved in Viral Infection and to Characterize Protein-Protein Interactions by Suratanee, Apichat
INAUGURAL-DISSERTATION
zur Erlangung der Doktorwu¨rde der
Naturwissenschaftlich-Mathematischen Gesamtfakulta¨t
der Ruprecht-Karls-Universita¨t Heidelberg
vorgelegt von
Apichat Suratanee, M.Sc.
aus Bangkok, Thailand
Tag der mu¨ndlichen Pru¨fung: 15.10.2012

Computational Analysis of RNAi Screening Data
to Identify Host Factors Involved in Viral
Infection and to Characterize Protein-Protein
Interactions
Gutachter: Prof. Dr. Roland Eils
Prof. Dr. Gerhard Reinelt

Abstract
The study of gene functions in a variety of different treatments, cell lines and organ-
isms has been facilitated by RNA interference (RNAi) technology that tracks the
phenotype of cells after silencing of particular genes. In this thesis, I describe two
computational approaches developed to analyze the image data from two different
RNAi screens. Firstly, I developed an alternative approach to detect host factors
(human proteins) that support virus growth and replication of cells infected with
the Hepatitis C virus (HCV). To identify the human proteins that are crucial for
the efficiency of viral infection, several RNAi experiments of viral-infected cells have
been conducted. However, the target lists from different laboratories have shown
only little overlap. This inconsistency might be caused not only by experimental
discrepancies, but also by not fully explored possibilities of the data analysis. Ob-
serving only viral intensity readouts from the experiments might be insufficient. In
this project, I describe our computational development as a new alternative ap-
proach to improve the reliability for the host factor identification. Our approach
is based on characterizing the clustering of infected cells. The idea is that viral
infection is spread by cell-cell contacts, or at least advantaged by the vicinity of
cells. Therefore, clustering of the HCV infected cells is observed during spreading
of the infection. We developed a clustering detection method basing on a distance-
based point pattern analysis (K -function) to identify knockdown genes in which
the clusters of HCV infected cells were reduced. The approach could significantly
separate between positive and negative controls and found good correlations be-
tween the clustering score and intensity readouts from the experimental screens. In
comparison to another clustering algorithm, the K -function method was superior
to Quadrat analysis method. Statistical normalization approaches were exploited
to identify protein targets from our clustering-based approach and the experimental
screens. Integrating results from our clustering method, intensity readout analy-
sis and secondary screen, we finally identified five promising host factors that are
suitable candidate targets for drug therapy.
Secondly, a machine learning based approach was developed to characterize
protein-protein interactions (PPIs) in a signaling network. The characterization
of each PPI is fundamental to our understanding of the complex signaling system
of a human cell. Experiments for PPI identification, such as yeast two-hybrid and
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FRET analysis, are resource-intensive, and, therefore, computational approaches
for analysing large-scale RNAi knockdown screens have become an important pur-
suit of inferring the functional similarities from the phenotypic similarities of the
down-regulated proteins. However, these methods did not provide a more detailed
characterization of the PPIs. In this project, I developed a new computational ap-
proach that is based on a machine learning technique which employs the mitotic
phenotypes of an RNAi screen. It enables the identification of the nature of a PPI,
i.e., if it is of rather activating or inhibiting nature. We established a systematic
classification using Support Vector Machines (SVMs) that was based on the pheno-
typic descriptors and used it to classify the interactions that activate or inhibit signal
transduction. The machines yielded promising results with good performance when
integrating different sets of published descriptors and our own developed descriptors
calculated from fractions of specific phenotypes, linear classification of phenotypes,
and phenotypic distance to distinct proteins. A comprehensive model generated
from the machines was used for further predictions. We investigated the nature of
pairs of interacting proteins and generated a consistency score that enhanced the
precisions of the classification results. We predicted the activating/inhibiting nature
for 214 PPIs with high confidence in signaling pathways and enabled to identify a
new subgroup of chemokine receptors. These findings might facilitate an enhanced
understanding of the cellular mechanisms during inflammation and immunologic
responses.
In summary, two computational approaches were developed to analyze the im-
age data of the different RNAi screens: 1) a clustering-based approach was used
to identify the host factors that are crucial for HCV infection; and 2) a machine
learning-based approach with various descriptors was employed to characterize PPI
activities. The results from the host factor analysis revealed novel target proteins
that are involved in the spread of the HCV. In addition, the results of the character-
ization of the PPIs lead to a better understanding of the signaling pathways. The
two large-scale RNAi data were successfully analyzed by our established approaches
to obtain new insights into virus biology and cellular signaling.
Zusammenfassung
Die Untersuchung von Genfunktionen in vielen verschiedenen Behandlungsver-
fahren, Zelllinien und Organismen wurde durch die Technologie der RNA Interferenz
(RNAi) ermo¨glicht, mit der der Pha¨notyp von Zellen nach Gen-Silencing bestimmter
Gene beobachtet werden kann. In der vorliegenden Arbeit beschreibe ich zwei com-
putergestu¨tzte Ansa¨tze, die zur Analyse von Bildern zweier unterschiedlicher RNAi
Screens entwickelt wurden. Erstens habe ich einen alternativen Ansatz entwickelt
um Host-Faktoren (menschliche Proteine) zu detektieren, die das Viruswachstum
sowie die Replikation von Zellen fo¨rdern, die mit dem Hepatitis C Virus (HCV)
infiziert sind. Verschiedene RNAi Experimente von virusinfizierten Zellen wurden
durchgefu¨hrt, um diejenigen menschlichen Proteine zu identifizieren, die entschei-
dend fu¨r die virale Infektionseffizienz sind. Trefferlisten aus verschiedenen Laboren
haben nur geringe U¨bereinstimmung gezeigt. Diese Unstimmigkeiten sind mo¨glicher-
weise nicht nur auf experimentelle Unterschiede zuru¨ckzufu¨hren, sondern auch auf
die Tatsache, dass die Mo¨glichkeiten der Datenanalyse nicht vollsta¨ndig ausgescho¨pft
wurden. Die ausschließliche Betrachtung der experimentell erzeugten viralen In-
tensita¨tswerte ist vermutlich unzureichend. In diesem Projekt beschreibe ich un-
sere computergestu¨tzte Entwicklung als einen neuen alternativen Ansatz, um die
Verla¨sslichkeit der Host-Faktor Identifikation zu verbessern. Unser Ansatz basiert
auf der Charakterisierung des Clusterings infizierter Zellen. Die Idee ist, dass Virus-
infektion durch Zell-Zell Kontakt verbreitet wird oder zumindest durch die Nach-
barschaft von Zellen begu¨nstigt wird. Daher betrachten wir das Clustering HCV
infizierter Zellen wa¨hrend der Infektionsverbreitung. Wir haben eine Clustering-
Detektionsmethode entwickelt, um Knockdown-Gene zu identifizieren, in denen die
Cluster von HCV infizierten Zellen reduziert waren. Die Methode verwendet eine
distanzbasierte Punktmuster-Analyse (K -function). Der Ansatz konnte signifikant
zwischen Positiv- und Negativ-Kontrollen unterscheiden und fand eine gute Korrela-
tion zwischen dem Clustering-Score und den Intensita¨tswerten der experimentellen
Screens. Im Vergleich zu einer anderen Clustering-Methode (Quadrat-Analyse) ist
die K -function u¨berlegen. Statistische Normalisierungsmethoden wurden angewen-
det um Ziel-Proteine aus unserem Cluster-basierten Ansatz und experimentellen
RNAi Screens zu identifizieren. Durch Integration von Ergebnissen unserer Anal-
yse, der Analyse von Intensita¨tswerten und einem sekundaren RNAi Screens, haben
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wir schließlich fu¨nf viel versprechende Host-Faktoren identifiziert, die geeignete Kan-
didaten fu¨r eine medikamento¨se Behandlung darstellen.
Zweitens wurde ein maschineller Lernansatz entwickelt, um Protein-Protein In-
teraktionen (PPI) in einem Signalnetzwerk zu charakterisieren. Die Charakter-
isierung jeder PPI ist elementar fu¨r unser Versta¨ndnis des komplexen Signal-
systems einer menschlichen Zelle. Experimente zur PPI Identifikation, wie z.B.
yeast two-hybrid und FRET Analysen, sind Ressourcen-intensiv und daher ist der
Ru¨ckschluss von pha¨notypischen A¨hnlichkeiten von herunterregulierten Proteinen
auf funktionelle A¨hnlichkeiten ein wichtiger Aspekt computergestu¨tzter Ansa¨tze zur
Analyse von umfangreichen RNAi Knockdown Screens. Diese Methoden lieferten je-
doch keine detaillierte Charakterisierung der PPIs. In diesem Projekt habe ich einen
neuen computergestu¨tzten Ansatz entwickelt, der auf einem maschinellen Lernansatz
basiert, der die mitotischen Pha¨notypen eines RNAi Screens verwendet. Der Ansatz
ermo¨glicht die Identifizierung des Wesens einer PPI, d.h. ob sie eher aktivierender
oder inhibierender Natur ist. Basierend auf den pha¨notypischen Deskriptoren haben
wir eine systematische Klassifizierung mittels Support Vektor Maschinen (SVMs)
etabliert um zu bestimmen, ob ein aktivierendes oder hemmendes Signal propagiert
wird. Die SVMs lieferten viel versprechende Ergebnisse mit guter Performanz durch
die Integration verschiedener Gruppen von publizierten Deskriptoren und unseren
selbst entwickelten Deskriptoren, die aus Fraktionen spezifischer Pha¨notypen, lin-
earer Klassifikation von Pha¨notypen und pha¨notypischen Distanzen zu bestimmten
Proteinen berechnet wurden. Ein umfassendes Modell, welches von den SVMs gener-
iert wurde, wurde fu¨r weitere Vorhersagen verwendet. Wir haben das Wesen von
Paaren von interagierenden Proteinen untersucht und einen Konsistenzwert gener-
iert, der die Pra¨zision der Klassifikationsergebnisse verbesserte. Wir konnten die
aktivierende/inhibierende Natur von 214 PPIs in Signaltransduktionswegen mit ho-
her Sicherheit vorhersagen und identifizierten eine neue Subgruppe von Cheomkin-
rezeptoren. Diese Ergebnisse tragen mo¨glicherweise zu einem besseren Versta¨ndnis
zellula¨rer Mechanismen bei, insbesondere wa¨hrend Entzu¨ndungsreaktionen und Im-
munantworten.
Zusammenfassend wurden zwei computergestu¨tzte Ansa¨tze zur Analyse der
Bilder der unterschiedlichen RNAi Screens entwickelt: 1) Es wurde ein Clus-
teringansatz verwendet, um Host-Faktoren zu identifizieren, die entscheidend fu¨r
eine HCV Infektion sind; und 2) wurde ein maschineller Lernansatz mit verschiede-
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nen Deskriptoren angewendet, um PPI Aktivita¨ten zu charakterisieren. Die Ergeb-
nisse der Host-Faktor Analysen konnten neue Zielproteine aufdecken, die an der
Verbreitung von HCV beteiligt sind. Daru¨ber hinaus fu¨hren die Ergebnisse zur
Charakterisierung der PPI zu einem besseren Versta¨ndnis von Signalwegen. Die
beiden umfangreichen RNAi Datensa¨tze konnten erfolgreich mit unseren etablierten
Ansa¨tzen analysiert werden, um neue Einblicke in die Virusbiologie und zellula¨re
Signalwege zu erhalten.
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Chapter 1
Introduction
1.1 Motivation
The discovery of the RNA interference (RNAi) technology is a major advance in
the identification of a specific gene’s function or role in signaling pathways. RNAi
is a naturally occurring cellular mechanism that permits the silencing of genes and
creates phenotypes that can provide clues to the function of these genes. Hence,
the technical application of RNAi has been developed on a genome-wide scale and
widely used to elucidate central aspects of cell biology. Notably, RNAi technology
allows for the analyses of a large variety of different treatments and cell lines, which
makes it a desirable approach for large-scale inferences of protein function. Besides
this, technologies using fluorescent reporters and imaging by microscopy have been
developed for the screening assays and this allows also single cells to be studied
over time. Numerous cellular phenotypes (e.g., cell shape, location and signaling
response) can be explored from these microscopy assays by using automatic im-
age analysis approaches and numerical features that represent cellular objects are
used in pattern recognition, machine learning techniques and statistical analyses for
functional analyses [4, 45, 55, 97, 98, 151, 152]. The exploratory data analysis of
the RNAi image data has posed challenges and has led to the identification of the
function of single human proteins, which correspond to the silenced genes.
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RNAi technology can be harnessed to identify drug targets. Several recent stud-
ies were reported systematic screening of gene knockdowns to identify host proteins
that might support HCV replication [5, 99, 132, 137]. By observing the viral infec-
tion after gene knockdown, the silenced genes that reduce the infection rate might be
suitable to be targets for drug development. These studies focused on inhibiting host
factors (human proteins) instead of viral proteins because human host-factor pro-
teins are evolutionary more stable and will not mutate into drug refractory variants.
However, the results from these studies showed only little overlap. This discrepency
might result from incomplete data analysis or differences in experimental conditions
of these studies. Therefore, an alternative method to improve the reliability of the
screens is required. Viral infection is spread effectively by cell-cell contacts. With
this mechanism, the clustering of infected cells can be observed during spreading of
the infection. To our knowledge an alternative computational method for identify-
ing viral host factors from infected cell localization has not been described earlier.
Rather than observing viral intensities which has been used for analyzing infected
cell images in traditional way, we developed a computational approach based on a
localization analysis of infected cells to identify host factors that might be suitable
for therapeutical drug targeting.
In addition, most of the functional processes in a cell involve interactions among
proteins. A better understanding of the complex protein-protein interactions can
support a better investigation in cell development and disease. To study the in-
teractions of proteins, a variety of high-throughput screens (e.g., the yeast 2-hybrid
system [129] or FRET analysis [163]) can be performed to obtain a vast amount of
interaction data. However, these approaches can be resource-intensive and infeasible
for many protein pairs. Thus, the development of computational approaches for the
characterization of protein interactions has become an important pursuit. Besides
this, several computational researchers studied protein functions and protein-protein
interactions from RNAi screening data using the image processing system, machine
learning techniques and statistical analysis in their researches [4, 45, 55, 97, 98].
However, using RNAi technology to better characterize protein-protein interactions
has not been performed yet. Identifying if two interacting proteins transduce a
rather activating or inhibiting signal can gain a better insight into their cellular
function and can be a useful information for pharmaceutical development. We
developed an approach based on a machine learning technique to predict the in-
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teractions to be activating or inhibiting signals. This approach used features from
both published phenotypic descriptors and our own developments calculated from
the fraction of phenotypes, linear classification approach from LDA analysis, and
distance with protein reference in the network. This integrative approach yielded a
more comprehensive model for further prediction.
1.2 Objective and scope
The goal of this thesis is twofold. First, we analyzed the RNAi data of cells infected
with the HCV and employed a clustering approach to identify the host factors that
are suitable as potential drug targets. The study focused on the clustering behavior
of the infected cells after genes were knocked down. The results of our clustering ap-
proach were compared with the data from experimental screens to identify potential
hits. Second, we analyzed the RNAi data of HeLa cells and developed a machine
learning technique for better characterizing known protein-protein interactions. The
characterization of protein-protein interactions enhance our understanding of the
underlying biological pathways and reveal protein cooperativity that is relevant to
disease mechanisms. This study focuses on the similarities between loss-of-function
phenotypes of different gene products that are involved in signal transduction path-
ways.
1.3 Outline of the thesis
Chapter 1 introduces the biological and biotechnical background and further topics
related to this thesis and reviews the existing computational methods that concerns
to RNAi data analysis, host factor identification and protein-protein characterization
analysis. Chapter 2 summarizes the methodologies and datasets applied in this
thesis. Detailed descriptions of the methods and algorithms, including the clustering
algorithm for detecting a group of infected cells and the machine learning technique
for predicting the activities of protein interactions are also provided. Chapter 3
reports the results of identifying host factors involved in viral infection and the
results of analyzing the signaling interactions using RNAi screening data. Chapter
4 provides the summary, discussion and outlook of this thesis.
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1.4 Publications
• A. Suratanee, I. Rebhan, P. Matula, A. Kumar, L. Kaderali, K. Rohr, R.
Bartenschlager, R. Eils, and R. Ko¨nig, Detecting host factors involved in virus
infection by observing the clustering of infected cells in siRNA screening im-
ages. Bioinformatics(Oxford) (26) 18, 2010.
• M. Gipp, G. Marcus, N. Harder, A. Suratanee, K. Rohr, R. Ko¨nig and R.
Ma¨nner. Haralick’s texture features computed by GPUs for biological appli-
cations. IAENG International Journal of Computer Science, 36(1), 2009.
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Hanoi, Vietnam, 2-6 March, 2009.
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The results of our research about the host factor identification have been published in
the journal Bioinformatics [133]. The manuscript covering the characterizing signal
interaction part is currently in preparation. A part of this project is involved in a
publication [47] published in IAENG International Journal of Computer Science.
1.5 Biological and technical background
In this section, I briefly summarize the biological and biotechnical background con-
cerning the application of my work. First, I briefly describe the process of RNAi to
promote the understanding of the data I analyzed. Next, I give a short overview
of the high-throughput RNAi screening technique used to generate the RNAi data.
Thereafter, I provide a short overview describing the biology of HCV. Finally, I give
an overview of signal transduction and protein-protein interactions.
1.5 Biological and technical background 5
Figure 1.1: DNA to protein. A complementary RNA copy is created from DNA
sequence during transcription. The genetic information is carried by the mRNA,
which is used to synthesize the protein molecules on the ribosomes. (The figure is
modified from http://de.wikipedia.org/wiki/MRNA).
1.5.1 RNA interference
A common approach used to discover the function of a gene is to down-regulate
the expression of the gene, which down-regulates the corresponding protein. The
phenotypic effects caused by this down-regulation are then studied. The discov-
ery of RNA interference (RNAi) or gene silencing using double stranded RNA has
allowed the disruption of expression. This RNAi is a cellular mechanism of post-
transcriptional gene silencing to prevent the cell from expressing foreign genetic
material, e.g., genetic material from a virus. In the nucleus of a normal cell (Figure
1.1), the DNA sequence of a gene is used as a template to synthesize the ribonu-
cleic acid (RNA) molecules during the processes of transcription. A protein-coding
gene that is copied into an RNA molecule is further processed into a messenger
RNA (mRNA). The mRNA is then transported into the cytoplasm and binds to
6 Introduction
Figure 1.2: RNA inference process. An enzyme of the Dicer family cleaves the RNA
into small pieces, called the siRNAs. The siRNA activates the RISC and aids in
the recognition of the complementary mRNA. The mRNA is cleaved and destroyed;
thus, the corresponding protein cannot be produced. (The figure is modified from
http://www.scbio.de/gene silencers.html).
a ribosome that translates the mRNA and produces the respective protein. The
mechanism of RNAi (Figure 1.2) initiates from a double stranded RNA (dsRNA)
in which one strand is complementary to a section of the mRNA. An enzyme of the
Dicer family proceeds to cleave and cut the RNA into small pieces called the small
interfering RNAs (siRNAs). Then, one strand of the siRNA called the antisense
strand becomes the ‘guide’, and the other strand becomes a temporary ‘passenger’,
which is quickly degraded [37]. The antisense strand (guide) is integrated into an
RNA-induced silencing complex (RISC) and then forms the activated RISC. The
antisense strand aids the RISC complex in the recognition of the complementary
mRNA, which it cleaves and systematically destroys the cognate RNA. The re-
spective protein cannot be produced after destruction of the mRNA by this RNAi
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process. To silence a gene, the siRNAs that have base-sequence complementarity to
the mRNA of the target gene are transfected into the cell.
1.5.2 High-throughput screening of the RNAi experiments
When laboratory automation (e.g., tissue culture facilities, arrayer robots, and plate
reader), software control, and computing infrastructure are employed, the use of
high-throughput screens allows millions of genetic tests to be rapidly conducted. The
application of RNAi technology to a high-throughput screen is a powerful method to
address many questions of cell biology. This loss-of-function screen is also particu-
larly useful for the analysis of signal transduction pathways [37]. In high-throughput
screens that use genome-wide siRNA knockdown experiments, approximately 22,000
human genes can be screened. To attain this number, the experiments can only be
performed after the optimization and automation of the experimental processes. In
384-well plates, the siRNA-gelatine transfection solution is prepared and then ar-
rayed into single-wells of the LabTek cover glass live cell imaging dishes. The spot
diameter is approximately 400 m, and the spot-to-spot distance is approximately
1125 m. These siRNA microarrays are dried and stored overnight. After drying,
the HeLa-H2B-GFP cells are plated on the microarrays and transfected by growing
these cells on the siRNA spots. Images are acquired with an automated microscope
every 30 min for 44 hours. The imaging starts 20 hours after plating the cells on
the siRNA microarrays. To image as many microarray spots as possible within a
time lapse of 30 min, the number of spots that can be imaged simultaneously, the
time spent at each spot and the desired temporal resolution have to be carefully
manipulated. Additional details of genome-wide high-throughput screens are also
available (e.g., [97, 98]).
1.5.3 Hepatitis C Virus
Approximately 170 million people are infected with the HCV worldwide [109]. The
HCV is a major cause of persistent chronic infections that lead to development of
steatosis, liver failure, liver cirrhosis and hepatocellular carcinoma [44]. The HCV
is a single-strand RNA virus that has an average incubation period of 6-8 weeks.
The HCV infection is often asymptomatic, and hence the detection of the HCV
at an early stage is difficult. Therefore, the HCV is often referred to as a “silent
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disease” [123]. The mechanism of the HCV life cycle is still unclear. A decade ago,
the model of viral entry was developed. It was found that a key cellular protein
for viral entry, CD81, is needed and binds to the viral structure protein E2 on the
surface of the HCV caspid [108]. Many more proteins were subsequently identified
as factors involved in the HCV entry, including two essential proteins, SR-BI and
claudin-1, as well as, accessory factors, such as glucosaminoglycans and low-density-
lipoprotein receptors (LDL receptors) [34, 42, 107, 121]. Generally, the viral envelope
protein of the HCV plays a central role in the HCV binding to host receptors and
membrane fusion. After the HCV uncoating, the viral genome is then translated
in preparation for viral replication. The translation of the viral genome generates
nonstructural and structural viral proteins, which are needed for the viral replication
and assembly of new viral particles. Viral replication is carried out in a convoluted
membrane structure called a membranous web. The newly synthesized viral RNA
strand is released from the membranous web and passed to the core protein via the
NS5A. The core protein is translocated onto the surface of a lipid droplet or an
endoplasmic reticulum (ER) membrane for efficient formation of the viral particles,
and then encloses the synthesized viral genome to form a capsid. The capsids are
enclosed by an endoplasmic membrane containing the viral envelope proteins and
are then released into the ER lumen. Finally, the viral particle is released from
the infected cells [95, 112]. The HCV has several mechanisms it employs to inhibit
the host response. The HCV infection induces an interferon response in the liver
of patients, and the expression of several HCV proteins has been shown to inhibit
and evade the innate antiviral response of host cells [65]. Recently, Moriishi and
coworkers reported that a HCV core protein cooperates with the host factors and
causes the lipid alternation, oxidative stress, and the progression of cell growth. To
maintain efficient viral replication and production, other viral proteins interact with
the host proteins, including molecular chaperones, membrane-anchoring proteins,
and enzymes associated with lipid metabolism [95]. Hence, the investigation of host
factors is progressing, and this progress is crucial for the discovery of treatments for
the HCV.
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1.5.4 Signal transduction and protein-protein interaction
networks
Cells typically receive chemical or mechanical cues from their environments. In
response to these cues, the cells send and propagate signals through signaling cas-
cades. There are many types of these pathways and they are commonly categorized
as metabolic pathways, gene regulatory pathways, or signal transduction pathways.
The metabolic pathways are well-studied and comprise a series of biochemical reac-
tions that maintain all cellular processes. To produce cellular energy or synthesize
cellular components, the metabolic pathways break down large nutrient molecules
(e.g., proteins, carbohydrates and fats) into small molecules. The gene regulatory
pathways or transcriptional regulatory pathways concern transcription factors, their
respective target genes, and the regulation between. Transcription factors bind to
the DNA at specific binding regions to stimulate or repress gene transcription, and
this binding regulates the production of the corresponding proteins. The signal
transduction pathways connect extracellular signals and transcription factors by a
complex system of interactions between signaling molecules within the cell. In a
typical signal transduction pathway, a receptor is a protein on the cellular surface
that receives and responds to a stimulus. An intracellular response is initiated after
the signal interacts with the receptors. The resulting message is transmitted by
specific proteins that trigger a specific action in the cell. Most of our understand-
ing of cellular processes is based on the identification and characterization of the
interactions between proteins and other biomolecules. These protein interactions
propagate the signal, which is the main process of signaling transduction. In this
thesis, I will use the term protein-protein interaction (PPI) to refer to a physical
interaction between proteins. Examples of PPIs include the phosphorylation, bind-
ing, and association of proteins to forming protein complexes. The second part of
this thesis characterizes the PPIs of signaling pathways.
1.6 Existing computational approaches
In this section, I review various existing computational approaches of analyzing
RNAi screening data that concerns to our works, i.e., the hit identification analysis
and protein-protein characterization analysis. I firstly explain existing approaches
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for analyzing the RNAi microscopy image data. Next, I describe existing approaches
for identifying host factors being important for viral infection. Finally, I explain the
existing approaches for inferring protein functions and protein-protein interactions
on a large scale.
1.6.1 Computational analysis of the RNAi image data
The use of fluorescence microscopy for the imaging of RNA interference (RNAi)
knockdown screens has become a preferred method to identify the protein function
of silenced genes and can be harnessed to detect potential drug targets. Computa-
tional approaches for automatic analysis of cell microscopy images after knocking
down genes have been successfully developed to describe the loss-of-function mor-
phological features. A goal of the RNAi knockdown screen is to study the effects
of experimental treatments on a cell population by comparing population-based
features. Usually, cell nuclei are the main labeled compartments of interest. Also
other subcellular structures, e.g., the cytoplasm, cytoskeleton, or proteins indicating
a specific cellular response (such as from virus infection) have been additionally la-
beled in separate channels [82, 92, 135, 153]. Studies were reported that investigated
single cells using phenotypic features such as cellular area, diameter, eccentricity,
texture, granularity, moment [18, 56, 64, 75, 98, 150]. The main steps for analyzing
the data consisted of (1) segmentation, (2) feature extraction, and (3) classifica-
tion. The aim of segmentation is to identify the cells in the images. The image is
seperated into different regions, each containing a single cell and the cells are seper-
ated from the background. This procedure can be done by several segmentation
algorithms, e.g., threshold- or edge-detection-based algorithms. For example, the
goal of the Otsu thresholding technique [100] is to find the optimal threshold that
separates the pixels into two populations (the cells and background) by minimizing
the in-class variance and maximizing the between-class variance. After each single
cell segmentation, cellular features are computed based on the identified single cell.
The features of a single cell are a numerical vectors representing the sizes, shapes,
or textures of a cellular object. These features can be analysed directly by compar-
ing the distributions of the features between two different experiments, e.g., normal
versus cancer nuclei, using statistical tests [87].
Additionally, when analyzing the cellular phenotypes, we wanted to observe only
specific cellular shapes occuring, e.g., during apoptosis or mitosis. In this case,
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machine learning techniques are required for learning the specific phenotypes and
performing the phenotypic prediction. Based on the extracted features and labeled
classes, machine learning techniques have been applied to classify cell nuclei into
different cell cycle phases [46, 97, 98, 151]. Held et al. [58] used an SVM technique
to classify cells into interphase, six mitotic stages and apoptosis based on 186 quan-
titative features describing texture and shape. Neumann et al. [97] used a live-cell
assay to profile the cell-division of the HeLa cells. They silenced each of 21,000
protein-coding human genes in a separate cell population using the RNAi method
and observed the effect using fluorescently labeled chromosomes that express his-
tones (H2B) tagged with the green fluorescent protein (GFP), followed by auto-
mated high-throughput time-lapse microscopy. They also used SVMs for classifying
the cell nuclei into several classes, e.g., interphase, mitosis, apoptosis, clustered nu-
clei, and artefacts, based on 214 extracted features of texture and shape. Harder
et al. [54, 57] extracted 376 features based on the size and shape, texture (Haralick
features), geometric moments, and granularity to classify imaged life cells into 12
classes of cell division cycle phases. A variety of applications followed extracting
the texture of RNAi transfected cells from large-scale cellular phenotypic assays,
and using machine learning methods allowing the classification of cells to identify
subcellular location [27, 104] and specific cellular features (e.g., the mitotic state and
viability of the cell) [18, 55, 56, 64, 75, 98, 150]. The classified phenotypes were used
for further analyses, e.g., to put-up models for cell division cycles or progression of
mitotic events [57, 97, 98]. Apart from the cell nucleus staining, also for additional
other cellular components these method were applied and the morphological features
were extracted using the fluorescent signal intensity [52, 92, 135] of the structure of
interest, e.g., of the mitotic spindle, centrosomes, or spliceosomes [48, 105]. Matula
et al. [92] analyzed the RNAi of cells infected with GFP expressing HCV. They mea-
sured the viral intensity from the GFP channel in cytoplasm and used the intensity
to compute the infection rate and classify each single cell into two classes (infected
and non-infected cells). The classification was performed by finding the optimal
intensity threshold that maximize the difference of the infection rates between the
positive and negative controls on a labtek. The target gene was identified from the
infection rate or from the average of viral intensity.
From the aboved studies, applications of the classification methods of morpho-
logical phenotypes were mostly used for finding sets of functionally related genes
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that showed similar knockdown phenotypes. We exploited the classification ap-
proaches for identifying infected cells to our new approach to identify human host
factors. Moreover, the methods for cellular phenotype classifications were exploited
for developing phenotypic descriptors related to calculation of phenotypic fraction
or phenotypic similarity to characterize activities of a protein-protein interaction.
1.6.2 Computational approaches for targeting host factors
Despite many substantial discoveries in virology, viruses remain a major cause of
severe diseases including Dengue fever, hepatitis, immune deficiency and severe in-
fluenza. Viruses employ specific human host proteins (i.e., host factors) for each step
of their ‘life’ cycle [19, 88, 91]. Discovering these host factors may not only unravel
the fundamental principles underlying the mechanisms of viral action (e.g., viral
replication), but also, notably, may lead to promising drug therapies that are not
affected by the high mutational variability in viral populations. Computational
approaches to determine human proteins involved with virus or other pathogens
mostly exploit information from available pathogen-host, protein-protein interac-
tion, or gene ontology databases [1, 69, 164]. The similarities or interactions of
host and pathogen sequences, structures, or domain-interactions are employed for
finally predicting the probability of the interactions between host proteins and the
pathogen [31, 33, 36]. Doolittle et al. [33] developed a computational approach for
predicting host factors for Dengue virus (DENV) for both the host (human) and the
vector (insect). The approach was based on the similarity of 3D protein structures
of DENV proteins and human proteins (hDENV-similar protein). They investigated
the interactions of hDENV and other target human proteins in the protein-protein
interaction database (the Human Protein Reference Database, HPRD) and predicted
that the target proteins might also interact with the DENV protein. However, these
methods based structure similarity and lack of predictions for viral proteins which
do not have a human homologous structure. Moreover, pathogens including viruses
show high variability and can evolve exploit the host proteins using various strate-
gies as well as effective escape machanisms [71]. Therefore, the network of virus
and human proteins are clearly dynamic and undergo diverse mechanisms of ac-
tions [71, 134]. Hence, these methods need to be further improved. Rather than
using the pathogen-host interaction analysis, RNAi knockdown screens have been
used and we propose a new technique for detecting host factors in this RNAi data
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in this thesis.
There are several genome-wide and more selected screens like e.g., kinase siRNA
screens using an infectious HCV to be brought into a cell culture to identify host
factors [77, 137, 142, 145]. One goal of these RNAi screens is to directly identify the
siRNAs (hits) that generate meaningful cellular phenotypes of cells infected with
the virus. Recently, Reiss and colleagues [115] performed an siRNA screen of the
human kinome to detect the host factor requirements for HCV replication. They
identified 13 different kinases that are required for HCV replication. However, most
of the previous results show the difficulty to obtain a consensus set of gene targets.
Li et al. [77] and Randall et al. [114] used siRNA against human host factors using
the same HCV genotype and modeled the human cell system. The results showed
only eight genes that overlapped across all platforms. This discrepancy might result
from incomplete data analysis or differences in the experimental conditions of these
studies, such as the use of different viral strains, time intervals or silencing sequences.
Brown et al. [14] showed the results of a computational analysis of genes identified
from four different experiments (protenomics, mRNA microarray, RNA-Seq, and
siRNA). They studied the effects of infecting cells with HCV by measuring changes of
infection. They performed pathway enrichment tests using GeneGOTM MetacoreTM
and revealed a greater overlap at the pathway level. They found 16 pathways which
were significantly enriched in three out of four experiments. These pathways are
known to be modulated by HCV infection. Therefore, this finding showed that
the development of an alternative approach might support to get insight from the
experimental data.
However, most of the studies for host identification are performed by the
RNAi experiments in the wet-lab and the results are analyzed with statistical ap-
proaches [9, 77, 114, 115, 137, 142, 145]. The statistical analysis for hit identification
is a bioinformatic approach that is an important step after conducting the knock-
down experiments to recover the set of important genes. To allow a comparison of
the data from different plates (labteks) and positions on these plates, data normal-
izations need to be conducted. A variety of current normalization approaches have
been developed to analyze the RNAi screens [89]. For the microscopy-based screens,
the mean or median fluorescence intensities of the cells in a spot are calculated.
These summarized values are used to normalize within and between different exper-
iments [7, 9, 115, 154]. For the RNAi screen of cells infected with a virus (e.g., the
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HCV or Dengue Virus), the viral expression of the GFP (intensity) is analyzed
based on the average fluorescence intensity per spot [115]. The normalization can
be performed using controls, such as siRNA controls with random, non-functional
sequences; this normalization is called a control-based normalization. In contrast,
the normalization can also be performed using all measured data as a control [7].
The normalization of the data from screens can be performed using the percentage
of control method, the normalized percent inhibition method, the z -score normaliza-
tion or the B-score normalization [7, 89]. The z -score is a measure of the standard
deviation away from the mean. The z -score is frequently used to normalize data of
high-throughput cell array screens; however, this method is sensitive to outliers. It
was suggested that the B-score normalization is a robust application of the z -score
normalization [89]. The B-score normalization accounts for row and column varia-
tions and has the advantage that it minimizes the biases from positional effects. To
reduce the row and column effects, B-score normalization uses a two-way median
polish procedure, which is an iterative algorithm that alternates row and column
operations. By using the medians rather than the means, the B-score normalization
is less affected by the presence of outliers. On each iteration of the two-way median
polish procedure, the row median, column median, and median of these medians
are computed and accumulated systematically into the row effects, column effects,
and an overall level effect. This procedure is continued until the value of the row
and column medians nears zero. The two-way median polish procedure is performed
for each plate. To account for plate-to-plate variablility, the resulting residuals of
each plate are then divided by their median absolute deviation (the median of the
absolute deviations of the medians) from all the residuals of the plate.
After the normalization, the data are processed to determine which genes differ
significantly from those of the negative controls, which identifies the hits or positives
from the screen. Screeners might simply select a discrete number of top scoring genes
from the screen as the hits. However, many hit identification techniques are available
to obtain the quality hits and reduce the risk of false positives. The hit identification
can be performed with the mean ± k standard deviation or median ± k median
absolute deviation. The genes are identified as hits if they surpass these thresholds.
The z -score normalization is simple and frequently used for the hit identification.
However, a robust z -score is preferred for hit identification. The robust z -score is
computed by subtracting the median instead of the mean from the measured values
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and then dividing by the median absolute deviation. The genes with low, significant
z -score values (P-value<0.05) are selected as the hits [9, 117].
From the above reviewed studies, the host factors were identified from the statis-
tical analyzing of the intensity readout of GFP-expressing viruses from knockdown
experiments or inferred from the pathogen-host analysis. However, there are prob-
lems regarding inconsistency of target lists and complexity of dynamic host-virus
networks. Therefore, an alternative approach is required to identify human target
genes that improve the reliability for host identification. In this thesis, we developed
a new approach based on cell localization to identify the host factors on the screens
and used the above statistical techniques to support the hit identification.
1.6.3 Inferring protein functions and protein-protein inter-
actions
The accurate reconstruction of signal transduction pathways within cells is central
to elucidating the cellular mechanisms of pathogenesis. The interactions within
signaling cascades are often specific to a given treatment or disease under investiga-
tion [74]. With the help of manual curation, the experimental validations of direct
PPIs and functional relationships have been extracted from the literature and as-
sembled in well-established databases [66, 68, 74, 128]. To identify new PPIs, a vast
amount of interaction data has been assembled from a variety of high-throughput
screens, including data from the yeast 2-hybrid system [129]. These screens can
be resource-intensive, especially if any possible interaction needs to be experimen-
tally investigated (e.g., 12.5 million experimental interaction assays for a selection
of 5,000 proteins). Therefore, the use of computational approaches is suggested
for the statistical inference of the PPIs using information from the co-expression of
genes, co-evolutionary studies and natural language processing (STRING [63, 136]).
Bakal et al. [4] used neural networks that based on morphological features of cells to
infer functional similarity from phenotype similarity of a smaller set of genes with
well-characterized functions. They first calculated 145 morphological features for
each cell to identify 7 classes of morphology that based on known phenotypes and
this was the result related to the perturbation of key signaling molecules (e.g., Rho
and Rac). They trained a set of artificial neural networks to identify these pheno-
types. The result was a matrix with seven columns; each represented the similarity
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score of the cell to the phenotypic category. They further performed a hierarchical
cluster analysis that allowed identification of the local signaling network with func-
tional characteristics regulating cell shape and migration. Fuchs et al. [45] described
an experimental and computational approach to predict gene functions basing on
changes in the morphology of individual cells within cell populations. They assessed
the effect of siRNA transfection on HeLa cells which DNA and the cytoskeletal pro-
teins actin and tubulin were stained. 51 morphological features were computed and
applied to SVMs. The classification results were employed to generate 13 pheno-
prints used to compute similarity distances. The clustering of genes was performed
based on the similarity distances and elucidated new functions of genes that were
involved in the organization of the spindle. Neumann et al. [98] analyzed time-lapse
microscopy siRNA data to identify a set of genes involved in cell division, migration
and survival. They computed about 200 morphological features for each single cell
and classified them into 16 phenotypic classes using SVMs. A phenotypic profile
of each class was computed that based on the time-lapse image sequence. They
performed hierarchical clustering of genes by their phenoprints in all morphological
classes, taking both the temporal change and the severity of the phenotype into ac-
count to identify a group of mitotic genes. The rationale of these approaches is that
similar cellular phenotypes will arise if the functions of the knocked-down genes
are tightly linked. For example, cellular phenotypes are expected if the proteins
corresponding to the knocked-down genes are part of the same protein complexes
or are mutually dependent for the propagation of signals. Recently, Vinayagam et
al. [149] developed an experimental and computational approach predicting the di-
rectionality of signal flow in a signaling network. They initially generated a PPI
network from yeast two-hybrid data and combined the information with publicly
available interaction data that resulted in a network comprising 1126 proteins and
2626 PPIs. The method predicted the flow of signaling cascades from membrane
receptors to transcription factors with the shortest path connections. They used a
naive Bayesian classifier for the prediction with 8 probability features of the direc-
tion between the proteins and yielded a good performance. Although the approach
was able to predict the signal flow, the study of the sign (activation and inhibition)
of the signal transduction has not been addressed.
Investigating how signal transduction by PPIs is mediated by phosphorylation
is an alternative way to gain insight into intracellular signal transduction. The
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goal of phosphorylation studies is to understand the nature of these phosphoryla-
tion interactions by mapping the phosphorylation sites and effector kinases. This
mapping aims to reconstruct a cellular signaling network [140]. The knowledge of
phosphorylation site prediction could be used for interpreting activating protein
pairs that a protein in the pair is a protein kinase that could be an evidence for a
protein-protein activation. Protein phosphorylation is a post-translational modifi-
cation of proteins that affects approximately one-third of all cellular proteins [26].
Both experimental and computational approaches have been developed for phos-
phorylation site detection. The software or databases for this detection have been
provided [125, 139, 140, 158, 159, 169]. Tan et al. [139] developed a sequence align-
ment approach to reconstruct conserved kinase-substrate networks. They identified
proteins that were tightly regulated by phosphorylation. Using topology features of
a predicted human phosphorylation network, a regulatory hub protein was found to
be highly phosphorylated, and the identified proteins were evidenced to be associ-
ated with various diseases, e.g., diabetes, cancer, or Alzheimer’s disease [139].
From the above reviewed studies, the aim of the study from Vinayagam et al. [149]
is closely related to our work. Most of the above studies addressed approaches for
inferring protein function or protein-protein interaction. However, they do not ad-
dress the question about the activities between the interacting proteins in signaling
transduction. The knowledge from predicting kinase-specific phosphorylation site
as mentioned above can support the activation interactions from our study.
1.7 Main contributions of this thesis
In the following, I summarize the main contributions of this thesis:
• Host factor identification in cells infected with the HCV
In this study, we investigated the HCV infection in a human hepatoma cell line
to detect human host factors that are necessary for viral infection. A compre-
hensive set of 719 genes expressing different kinases was screened by employing
the RNAi technology [115]. We developed a computational approach basing on
a well-known point pattern analysis approach, the K -function, to detect clus-
tering of the cells (see Section 2.1.4). This approach observed a reduction of
viral infection in a reduced grouping (clustering) of the infected cells. For each
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knockdown experiment, we compared the clustering of the infected and non-
infected cells and estimated the reduction in clustering of the infected cells. We
also applied an alternative clustering method, the quadrat analysis, to mea-
sure the infection phenomena of the cell distribution (see this method in Sec-
tion 2.1.4 and the results in Section 3.1.1). Different bioinformatics approaches
were applied to the data to identify the host factors that significantly reduce
the HCV infection efficiency. We employed a statistical method described re-
cently using B-score and z -score normalization of the intensity readouts from
the segmented cellular images [13], the intensity readouts of a luciferase based
secondary screen and our clustering scores (see Section 2.1.6). We yielded 30
promising candidates suiting as potential host factors for therapeutical drug
targeting. Five of these candidates were found using all three methods: the
CD81, PI4KA, CSNK2A1, SLAMF6 and FLT4 (see Section 3.1.1). In conclu-
sion, we report an alternative method for high-throughput imaging methods
to detect host factors being relevant for the infection efficiency of viruses.
This method is generic and has the potential to be used for a large variety of
different viruses and treatments being screened by imaging techniques.
• Characterization of signaling interactions
The aim of our study was to elucidate if two interacting proteins positively
propagate a signal (activation) or if their interaction rather lead to a con-
version of the original signal (inhibition). For this, we developed a workflow
that employed a machine learning approach based on the idea that activat-
ing signals lead to similar knockdown phenotypes of the respective interacting
proteins, whereas the inhibitory signals lead to rather dissimilar phenotypes
(see Section 2.2.1). We used a large range of phenotypic descriptors calcu-
lated from fractions of specific phenotypes, linear classification of phenotypes,
and phenotypic distance to distinct proteins (see Sections 2.2.5 and Section
3.2.2). We applied this approach to cellular images collected in the Mitocheck
genome-wide RNAi knockdown screen [98]. Support Vector Machines were
employed for the interaction classification (see Section 2.2.6). With this, char-
acterizations of protein-protein interactions were identified. The results from
classifications showed that our methods can be used to classify interactions as
having a role in the activation or inhibition of signal transduction with AUC
of 0.76 (see Section 3.2.3). Consistency score was established for investigat-
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ing the nature of pairs of interacting proteins (see Section 2.2.9). This score
used the performance criteria of the machine learning method to estimate
the consistence of pairs of individually knocked-down genes. The relevance
of our consistency scores was validated using other independent databases
through GSEA enrichment tests (see this method in Section 2.2.10 and the
results in Section 3.2.4). In a case study, we analyzed the signal transduction
pathways leading from the cytokine receptors to the transcription factors that
were known to be controlled by these pathways.
Chapter 2
Methods
This chapter is divided into two parts. Section 2.1 describes the methods used
to detect the host factors necessary for viral replication and the analysis of the
clustering of cells infected with HCV. The clustering approach, which is based on the
spatial distance, and the statistical analysis for defining hits are described. Section
2.2 describes the general workflow and methods used for the characterization of
the PPIs as having a role in the activation or inhibition of signal transduction
and includes a detailed description for generating the phenotypic descriptors. The
classification approach and the measurement of its classification performance are
also explained.
2.1 Clustering of cells infected with Hepatitis C
Virus
2.1.1 General concept and workflow
The detection of human proteins that are involved in viral entry and replication is
facilitated by the modern high-throughput RNAi screening technology. However, the
hit lists from different laboratories have shown only little consistency. This lack of
agreement might result from experimental discrepancies or unexplored possibilities
in the data analysis. We would like to improve the reliability of the RNAi screens by
combining a population analysis of infected cells with an established dye intensity
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Figure 2.1: The workflow used to identify the host factors that are crucial for viral
infection efficiency. The RNAi data of cells infected with HCV are generated as two
channel image data (the DAPI-stained cell nuclei and the GFP expressed by the
virus). An automated imaging system is employed to identify the infected and non-
infected cells. A clustering approach is then performed to analyze the clustering of
infected cells. Statistical methods are applied to identify potential hits by comparing
the hits from the clustering approach with the hits from a standard procedure and
a secondary screen.
readout. The viral infection is mainly spread by cell-cell contacts, and the clustering
of infected cells can be observed during spreading of the infection in situ and in vivo.
We employed this clustering feature to define the knockdowns that harm the viral
infection efficiency of the human HCV. Images of the cells that were knocked down
for 719 human kinase genes were analyzed with an established point pattern analysis
method, Ripley’s K -function. This method was used to detect knockdown cells in
which the viral infection did not show any clustering and therefore were hindered
to spread their infection to the neighboring cells. The results were compared in a
statistical analysis that used intensity readouts of the GFP-expressing viruses and
a luciferase-based secondary screen. Five promising host factors were identified and
are suitable as potential targets for drug therapy.
An overview of our workflow is shown in Figure 2.1. During screening, images
were taken under fluorescence microscopy of the infected human cells with knocked-
down genes. The cells were cultured and treated on printed plates, and the siRNA
and transfection reagents were spotted on a chamber plate at known locations in a
grid pattern. Only the cells located within the area of a printed spot took up the
corresponding siRNA and underwent gene silencing. The two-channel images were
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acquired using an automated fluorescence microscope. The first channel displayed
DAPI stained cell nuclei. The second channel represented a viral expressed fluo-
rescence protein (GFP, Green Fluorescence Protein). An automated system, which
was described in detail by Matula and coworkers [92], was employed. In the DAPI
channel, the single-cell nuclei were segmented, and the viral protein production lev-
els (viral signal) of each cell were computed by the mean intensity in channel 2.
According to the viral signal, the cells were classified as infected or non-infected
based on a thresholding procedure. The cells with a viral signal that was less than
the threshold were classified as non-infected, otherwise cells were classified as in-
fected. The threshold was defined by maximizing the difference in the infection
rates between the positive and negative controls, which were spotted on the same
plate. We applied the K -function to the spot distributions using the local spatial
variation, which is a statistical clustering method. We found candidate host factors
that are suitable for therapeutical drug targeting.
2.1.2 Data source
The experimental data were generated by our collaborator, Ilka Rebhan at the
Department of Molecular Virology, Universita¨tsKlinikum Heidelberg. The siRNA
library used for the primary screen of this study was purchased from Ambion (Si-
lencer R© Human Kinase siRNA Library V3 (AM80010V3)). The reverse transfection
of the siRNAs into Huh7.5 cells [8] in a LabTek format was optimized according to a
previously described protocol [39]. Overall, 2157 siRNAs targeting 719 human kinase
genes plus positive controls targeting the entry receptor CD81 or the viral genome
itself (HCV321 and HCV138) and four different negative controls (non-silencing
siRNA) were spotted in transfection mixture onto LabTeks. After the seeding of
the Huh7.5 cells, we allowed the siRNA silencing to occur for 36h. The cells were
infected with a HCV GFP reporter virus, fixed 36h later and immunostained with a
GFP-specific antibody. The cellular arrays were imaged with a scanning microscope
(ScanˆR, Olympus Biosystems) using the 10x objective (Olympus, cat. no. UP-
SLAPO 10x), and images were analyzed with an image analysis method (see Section
2.1.3). The primary screen was repeated in 12 times. All images with less than 125
or more than 500 cells within the siRNA spots were excluded from the analysis. As
an additional quality control for staining artifacts, all images were analyzed by eye;
this quality control step resulted in the exclusion of 15% of the images. Statistical
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analysis was performed to compute a mean z -score and a P -value for each gene to
facilitate the selection of candidate genes (Section 2.1.6). During the validation of
178 gene candidates selected from the primary screen, three independent siRNAs
per gene were used to minimize the number of potential off-target hits. In addi-
tion, the format of the assay was changed to a statistically more robust 96-well
plate format to increase the number of transfected cells per siRNA and thus the
statistical power of the assay (approximately 300 cells in the LabTek format but
approximately 10,000 in this well-based assay). The solid phase method of reverse
siRNA transfection was adapted to the 96-well plate format as described by Erfle
and coworkers [40]. Briefly, the siRNAs are printed together with a gelatin solution
at defined locations on the glass slides. After drying the wells, the substrates can be
stored for up to 15 months without any loss in efficacy or directly used for knockdown
studies. This method is called a “reverse transfection” because the order of addition
of the siRNAs or expression plasmids and cells is reversed in comparison with the
conventional transfection method [39, 40]. This assay format allowed the use of a
luciferase reporter virus that also facilitated the analysis of the screen. To validate
the effects of the kinase knockdown experiments on the HCV entry and replication,
5 x 103 Huh7.5FLuc cells (stably expressing firefly luciferase) were seeded in each
siRNA-coated well of a 96-well plate. After 36h, the cells were infected with a HCV
renilla luciferase reporter virus. Forty-eight hours post-infection, the cells were har-
vested, and the firefly luciferase and renilla luciferase activities were measured. The
secondary screen was performed twice in duplicates.
2.1.3 Image analysis of HCV infected cells
To analyze the images of the siRNA screen, an automated system, which is described
in detail elsewhere [92], was employed. Briefly, the inputs of this system consisted
of two dye-channel images from a chamber plate with printed siRNA spots. The
fluorescence signals originated from the DAPI-stained cell nuclei (1st channel) and
Green Fluorescence Protein (GFP), that incorporated into the viral strain (2nd chan-
nel). In the DAPI channel, the single-cell nuclei were segmented using an edge-based
approach that combined the responses of the gradient magnitude and the Laplacian
of the Gaussian filters with the morphological closing and hole filling operators. The
nuclei were identified among the segmented objects by applying the size, intensity,
and circularity criteria. The viral protein production level (virus signal) of each cell
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was computed using the mean intensity in channel 2 inside the nucleus neighbor-
hood. The positive and negative controls were spotted on each plate. In the positive
controls, the siRNAs hindered viral protein production, which resulted in a low vi-
ral signal; whereas, in the negative controls, the viral replication was unaltered.
According to the viral signal, the cells were classified as infected or non-infected
using a thresholding concept. The cells with a viral signal less than the threshold
were classified as non-infected, otherwise the cells were classified as infected. The
threshold was defined by maximizing the difference in the infection rates between
the positive and negative controls, which were spotted on the same plate. Quality
filtering was performed to eliminate the out-of-focus images and image artifacts. On
the single image level, the images were automatically classified as low quality if they
contained too few or too many cells or if they were out-of-focus. On the whole plate
level, the percentage of saturated pixels in channel 2 was computed. Over-exposed
plates were scanned again using decreased exposure times [92].
2.1.4 Clustering of infected cells
K -function
The K -function or Ripley’s K -function is a well-established measure for defining the
degree of clustering. This measure evaluates all interparticle distances over the stud-
ied area and compares the observed distribution with a random distribution of spots.
Ripley’s K -function has been used in ecology, epidemiology and geography [41]. In
cell biology, the function was applied to study the integrin-sensing extracellular ma-
trix properties [102] and to analyze lipid rafts by observing the clustering of the RAS
proteins [110].
The distribution of cells in fluorescence microscopy images was represented as a
spatial pattern of spots. The spots (cells) were classified as infected or non-infected,
and their respective clustering behaviors were studied using the K -function. The
K -function function was introduced by Ripley in 1977 [118]. The K -function is a
distance-based method of measuring the ratio of the expected number of neighbors
within a circle with a given radius c(r) to the expected density. The K -function is
calculated using the equation
K(r) =
1
λ
N∑
i=1
N∑
j=1,i 6=j
1
w(xi, dij)
Ir(dij)
N
(2.1)
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for a given radius parameter r>0. The variables of the equation include the follow-
ing: N is the number of spots in the observed area A (whole image); λ is the intensity
of spots, which can be estimated by N
A
; dij is the Euclidean distance between the
spots i and j. The function Ir(dij) is equal to one if dij < r and is zero otherwise.
Since each point’s neighborhood is only defined within a given study area, points
close to the area’s boundary need to be processed with edge correction to get an
accurate estimation. The weighting factor w(xi, dij) corrects for the edge effects and
is the proportion of the circumference of a circle with center xi and distance dij that
falls in the studied area. Let c+i (r) and c
−
i (r) be the regions of the search circle of
a point i that belong or do not belong to the study area, respectively. We usually
do not know the number of points within c−i (r). If the points in this area are not
considered, we might find points in ci(r) that are lower than expected. Suppose
that the point density within c−i (r) is equal to the point density within c
+
i (r). Let
us define the total number of points within ci(r) as the following:
ni(r) = n
+
i (r) + n
−
i (r) (2.2)
where n+i (r) and n
−
i (r) are the number of points within c
+
i (r) and c
−
i (r), respectively.
The area of the circle, ci(r), can be defined as
Areai(r) = Area
+
i (r) + Area
−
i (r) = pir
2 (2.3)
where Area+i (r) and Area
−
i (r) are the areas of the region within c
+
i (r) and c
−
i (r),
respectively. Using the density definition and above assumption, we find the follow-
ing:
n−i (r)
Area−i (r)
=
n+i (r)
Area+i (r)
n−i (r) =
Area−i (r)
Area+i (r)
n+i (r). (2.4)
From equation (2.2), (2.3) and (2.4), it follows that
ni(r) =
Areai(r)
Area+i (r)
n+i (r) =
pir2
Area+i (r)
n+i (r) =
1
w(xi, dij)
n+i (r). (2.5)
When the circle is entirely inside of the studied area, Area+i (r) is equal to pir
2,
ni(r) = n
+
i (r) and w(xi, dij) = 1. From equation (2.1) and equation (2.5), we obtain
the following:
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(a) (b) (c)
Figure 2.2: Examples of three different point patterns. (a) random distribution of
spots; (b) clustering spots; (c) regular pattern. The normalized clustering scores for
the random distribution, clustering spots, and regular patterns are 0.03, 0.98, and
-1.02, respectively.
Kˆ(r) =
1
λ
1
N
N∑
i=1
ni(r) =
1
λ
pir2
(
1
N
N∑
i=1
n+i (r)
Area+i (r)
)
=
1
λ
·
(
λˆpir2
)
, (2.6)
where the λˆ is the density estimation. Ripley’s K -function is used to compare the
observed spot distribution with a random distribution. The given spot distribution
is tested against the null hypothesis that the spots are randomly distributed. For
clustering distributions, the expected value of K(r) is larger than the value of a
random distribution; for regular patterns, this expected value is less than for a
random distribution. For the complete spatial randomness (CSR) and assuming
the points are randomly distributed, the average neighborhood density is equal to
pir2. In equation (2.6), if the points adhere to the CSR, λˆ = λ and Kˆ(r) = pir2.
Furthermore, if λˆ < λ, then the average neighborhood density is less than the
expected, which means that points are dispersed and the Kˆ(r) < pir2. If λˆ > λ,
then the average neighborhood density is greater than expected, which means that
the points are clustered and Kˆ(r) > pir2 [130]. Figure 2.2 shows examples of the
spot distributions for the random, clustering, and regular distribution; the plot of
Kˆ(r) is shown in Figure 2.3.
To correct for the biases caused by the clustering of proliferating cells, we used a
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(a) (b) (c)
Figure 2.3: Estimated K -values for the point patterns. Solid curves are the plots of
the inhomogeneous K -function for the data of Figure 2.2. (a) random distribution
of spots; (b) clustering spots; (c) regular pattern). Dashed curves represent the K
values of the complete spatial randomness (CSR) distributions, which were used as
controls. The normalized clustering scores for the random distribution, clustering
spots, and regular patterns are 0.03, 0.98, and -1.02, respectively.
random distribution that used the actual positions of the spots of infected and non-
infected cells. The sth simulated null-hypothesis of the K -function was estimated
by randomly drawing Nc spots from all spots (infected and non-infected cells) and
applying them to the K -function. The final null-hypothesis was calculated from
the mean value of these simulated K -functions (s = 1, . . . ,100). We applied K -
function to the spot distributions using the local spatial variation (independent from
their clustering) and the inhomogeneous K -function as defined by Baddeley and co-
workers [3]. The inhomogeneous K-function is given by the following equation:
Kinhom(r) =
1
|A|
N∑
i=1
N∑
j=1,i 6=j
eijIr(dij)
λ(yi)λ(yj)
(2.7)
where |A| denotes the observation area (distance ≤ r) and eij is the edge-correction
factor calculated by the border method [119]. λ(yi) and λ(yj) are estimated inten-
sities at spots yi and yj. These variables were estimated using a Gaussian kernel
smoother and the intensity surface model [3]. The maximum ranges of the radius
r that we investigated were 25%, 30%, 35%, and 40% of the shorter side of the
whole image. To obtain the clustering score, the area between the curves of the
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(a) (b) (c)
Figure 2.4: Three point pattern distributions with different VMR scores. The VMR
scores for the random distribution, clustering spots, and regular patterns are 1.21,
17.97, and 0.27, respectively.
inhomogeneous K -function and a simulated random distribution was calculated.
The score was positive if the curve for the inhomogeneous K -function was mainly
above the curve of the simulated random distribution (tendency for clustering),
and the score was negative otherwise. This score was calculated for the infected
and non-infected cells, respectively. To estimate the infection rate using the final
clustering score, the score of the infected cells was subtracted by the score of the
non-infected cells. The library spatstat [2] in the R-programming environments was
used to compute the estimated K -value.
Quadrat Analysis
We also observed the clustering of cells with another clustering method, which is
called a quadrat analysis. The quadrat analysis observes the frequency distribution
of cells within a set of grid squares (quadrat) [156]. To obtain the variance-mean
ratio (VMR) as a measure of the clustering of points, the mean number of cells per
quadrat is estimated, and its variance is computed using the following:
VMR =
s2
x¯
, (2.8)
s2 =
m∑
i=1
(xi − x¯)2
m− 1 , (2.9)
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where m is the number of quadrats, xi is the number of points in quadrat i and x¯
is the mean of the number of points per quadrat. A VMR value of greater than one
indicates a clustered distribution, a VMR value of less than one indicates a random
distribution and a VMR = 0 indicates a uniform distribution. The VMR scores for
the random, cluster and regular distributions are shown in Figure 2.4. The VMR
scores were computed with a 4x4 grid quadrant and yielded the following: a score
of 1.209, which is nearly one for the random distribution; a score of 17.97, which is
much higher than one for the clustered distribution; and a score of 0.29, which is
less than one for the uniform or regular distribution. To obtain the final clustering
score, we subtracted the VMR scores of the non-infected cells from the VMR scores
of the infected cells. The clustering score was calculated for all knocked-down genes
and the controls, and a z -normalization was performed.
2.1.5 Comparing the clustering results and experimental re-
sults
We investigated the results of the clustering approaches by comparing the z -scores
from K -function and Quadrat Analysis for all knocked-down genes with the z -score
from the intensity readouts of the primary and secondary screens. The Pearson
correlation coefficient was employed for this comparison. Given the scores of all
knocked-down genes from the clustering approach, X = (x1, x2, x3, . . . , xn), and the
intensity readouts from the experiments, Y = (y1, y2, y3, . . . , yn). The correlation
coefficient can be computed as follows:
R =
cov(X, Y )√
var(X)var(Y )
(2.10)
where cov(X, Y ) is the covariance between X and Y, cov(X, Y ) =
∑n
i=1(xi − x¯) ×
(yi − y¯), and var is the variance of the data, var(X) =
√∑n
i=1(xi − x¯)2, var(Y ) =√∑n
i=1(yi − y¯)2. The correlation coefficient values range from -1 to +1. If the corre-
lation coefficient is close to 1, the clustering scores are consistent with the intensity
values from the experiments, whereas a correlation coefficient that is close to -1
suggests that the score and the intensity have an opposite tendency. A correlation
coefficient of 0 means that no linear relationship exists between the score and the
intensity.
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2.1.6 The statistical method used to identify the host
siRNA hits
For the primary screen, we excluded the wells with less than 125 and more than
500 cells. For the secondary screen, the wells showing the lowest and highest 5% of
the firefly reporter activity (correlated to the number of viable cells) were excluded.
These wells were excluded to eliminate possible interference with the readout of
viral replication from cytostatic or cytotoxic effects or high variability in the cell
number. In some wells, the cells might have grown densely and it is possible that
incorrect segmentation of images occurred [9]. The viral-specific signal intensities per
siRNA were normalized for the effects of differing cell counts using a local-weighted
scatterplot smoothing method [25].
The B-score normalization was used to remove the spatial effects within indi-
vidual LabTeks [13] and accounted for the row and column variation effects. The
variability between plates was addressed by subtracting the plate median from each
measurement per siRNA and then dividing the resulting value by the plate median
absolute deviation (1σ), which resulted in one score per siRNA per LabTek. The
advantage of the B-score normalization is that it minimizes the biases due to posi-
tional effects [89]. To compute the B-score, first we calculated the residual rijp for
the row i and column j on the plate p which is defined as the following:
rijp = yijp − yˆijp = yijp − (µˆp + Rˆip + Cˆjp). (2.11)
The residual is the difference between the measured value yijp and the fitted value
yˆijp that is computed from the estimated average of the plate (µˆp) and the estimated
systematic measurement offsets for each row i on plate p (Rˆjp) and column j on plate
p (Cˆjp). The B-score is calculated by the following:
B-Score =
rijp
MADp
, (2.12)
where MADp is the adjusted median absolute deviation for each plate p; MADp is a
robust estimate of the spreading of rijp: MADp = median {| rijp −median(rijp)|}.
The replicates were summarized using the mean of the normalized scores; further-
more, Student’s t-tests were carried out to determine whether the siRNA effects
differed significantly from zero. Only the hits with negative z -scores were taken.
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For all three analyses (the primary screen, secondary screen, and clustering analy-
sis), the hits were selected if their P -values were below 0.05. The statistical analysis
of the processed imaging data was carried out using the R-programming language
and integrating the Bioconductor libraries RNAither [117] and cellHTS [12].
2.2 Characterization of the signaling interactions
2.2.1 General concept and workflow
An overview of our workflow is shown in Figure 2.5. First, the cellular pheno-
types from the RNAi screening images were quantitatively measured and analyzed.
Protein interactions (activation and inhibition of signal transduction) were assem-
bled from the database KEGG [66, 67, 155], and these interactions were used as a
gold standard. We generated novel phenotypic features describing the similarity of
phenotypes between two proteins. In addition, the phenotypic features from the
original study of the image data [98] were assembled. We then established a sys-
tematic classification using the Support Vector Machines (SVMs) that was based
on the phenotypic descriptors used to classify the set of interactions that activate
or inhibit signal transduction. The trained machines were evaluated and then used
as a prediction model for unknown interactions. All interactions were used to de-
fine a similarity score, which is called the consistency score. The performance was
improved using this score. The consistency score was verified with other interaction
databases. We applied the consistency score for a detailed analysis of the cytokine
receptor signaling. Unsupervised clustering was performed to find proteins that have
similar functions. A cluster with a predicted domain of interaction was investigated
in further detail.
2.2.2 Data sources
List of interactions from KEGG that activate or inhibit signal transduc-
tion
The characterizations of the PPIs in signaling pathways that were used to construct
the human signaling network were obtained from the Kyoto Encyclopedia of Genes
and Genomes (KEGG, www.genome.jp/kegg) [66, 67, 155]. The KEGG provides
a comprehensive set of interactions which are linked to the supporting literature
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Figure 2.5: The workflow for the prediction of interactions that are involved in
the activation and inhibition of signal transduction using the pairwise phenotypic
similarity features and SVMs.
evidence. We used the lists of activation (Act-PPI) and inhibition (Inh-PPI) from
eleven signaling pathways (Table 2.1) that had a high overlap with the cytokine
receptors such as those from the endocrine signaling system, cell growth and death
and the immune system. In total, we had phenotypic data for 663 proteins for
which we had phenotypic data were investigated. Among these, we got 1927 known
activation and 676 known inhibition interactions. The protein pairs of all sets (Act-
PPI, Inh-PPI) were further analyzed.
We also used the PPIs from the Search Tool for the Retrieval of Interacting
Genes/proteins (STRING) version 9.0 [136] and the MetaCoreTM (www.genego.com)
to perform the enrichment analysis. The STRING database includes an interaction
database of known and predicted PPIs. The MetaCore database is an interaction
database that provides additional pairs of interacting proteins.
Cellular imaging data
The morphological changes in the nuclei of HeLa cell clones that were stably trans-
fected with the GFP-tagged histone 2B were tracked by fluorescence imaging af-
ter the transient transfection of the siRNAs in the high-throughput screens. The
2.2 Characterization of the signaling interactions 33
Table 2.1: The list of the selected pathways from the KEGG database.
Signaling pathways KEGG ids Pathway groups
Insulin hsa:04910 Endocrine system
VEGF hsa:04370 Signal transduction
MAPK hsa:04010 Signal transduction
ERBB hsa:04012 Signal transduction
mTOR hsa:04150 Signal transduction
WNT hsa:04310 Signal transduction
TGF-beta hsa:04350 Signal transduction
Jak-STAT hsa:04630 Signal transduction
Cell cycle hsa:04110 Cell Growth and Death
Chemokine signaling pathway hsa:04062 Immune System
Cytokine-cytokine receptor interac-
tion
hsa:04060 Signaling molecules and
interactions
cells were distributed on the cell microarrays (labteks) that were printed with the
transfection-ready siRNAs, and the chromosome/nuclear morphology was visualized
in real-time. One image contained more than 100 nuclei with an average diameter of
approximately 30 pixels in the G1 phase. All images had a grey value depth of 16 bit
and a spatial resolution of 1344x1024 pixels. Each image sequence consisted of 96
time points over 48 hours. The analyzed images were obtained from the Mitocheck
Database.
2.2.3 Machine learning for classification: the LDA and SVM
The machine learning approach is a computational method for the design and de-
velopment of algorithms capable of learning empirical data. A major task of the
machine learning approach is to recognize patterns and then makes an intelligent
decision based on the learned data. The machine learning approach is mainly cate-
gorized into supervised and unsupervised learning methods. A supervised learning
method requires the training data with correctly predefined classes for learning and
produces an inferred function (a classifier or a regression function). In contrast, an
unsupervised learning approach, such as clustering and association rules, is based
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on a data distribution in a feature space without predefined classes and describes
hidden patterns in the data. The general elements of the classification task in the
machine learning approach are comprised of the following: 1) learned data, 2) learn-
ing algorithms (e.g., the Support Vector Machine, Random Forest, Decision Tree,
and Na¨ıve Bayes), and 3) performance evaluations of the classifier. To measure the
ability of the classifier to perform accurately on new (untrained) data, the learned
data are divided into training and testing sets. The learning algorithm learns from
the training set and tests on the testing set.
In this project, we focused on the supervised learning approaches, such as linear
discriminant analysis (LDA) and a Support Vector Machine (SVM). We used LDA
and a SVM for several tasks. LDA was trained to classify two sets of cellular
phenotypes resulting from the knockdown of different genes. The accuracy of this
classification was the similarity of the two knockdown phenotypes. For the SVM,
we first used it to classify each single cell into four phenotypic classes (apoptosis,
interphase, mitosis, and shape) and computed the fraction of each phenotype with
respect to the number of cells in an knockdown image. Second, we used the SVM to
distinguish the activities of the PPIs, which consisted of the activation and inhibition
of signal transduction. Both LDA and the SVM are supervised machine learning
approaches. The supervised learning method requires prior knowledge of a set of
objects, which are composed of values of their descriptors and class labels. For
the LDA, the descriptors are the image features (Section 2.2.4), and the classes are
the two groups to which the single cells belong. For the SVM classification of the
four phenotypes, the descriptors are also the image features (Section 2.2.4), and
the classes are the four class labels. For the SVM classification of the types of
PPIs, the descriptors are the pairwise phenotypic descriptors (Section 2.2.5), and
the classes are the labels of activation and inhibition. After the training procedure,
the classifiers are applied to superimpose the class labels from the given descriptors
on new objects for which the class labels are unknown. The principle of LDA and
the SVM is briefly described in the following sections.
2.2.3.1 Linear discriminant analysis
Linear discriminant analysis (LDA) is an approach widely used in classifications
that are based on the linear combinations of feature vectors. The method performs
feature dimensionality reduction while preserving the class separability and charac-
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(a) (b)
Figure 2.6: Two-dimensional case of projecting the sample on a line. Figure (a)
shows two sample groups that are mixed on the projected line. Figure (b) shows
two sample groups that are separated by the projected line.
terizes two or more classes of the data with the highest conditional probability. The
resulting combination uses a linear classifier. A criterion of the linear discriminant
is that the ratio of the between-class to within-class scatter must be maximized.
The sample x is projected onto a line by y = wTx. The optimal line is the line
that maximizes the separation of two or more classes. Figure 2.6(b) shows the opti-
mal line for the separation of the two-dimensional samples, whereas the two groups
cannot be separated by the line in Figure 2.6(a).
To find a suitable projection vector, the mean vector of each class in the x and
y feature spaces uses the following as a measure:
µi =
1
Ni
∑
x∈ci
x, (2.13)
and µ˜i =
1
Ni
∑
y∈ci y =
1
Ni
∑
x∈ci w
Tx = wTµi.
The objective function is the distance between the projected means and is given by
the following:
J(w) = |µ˜1 − µ˜2| =
∣∣wT(µ1 − µ2)∣∣ . (2.14)
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Figure 2.7: An example of a data projection considering the means and standard
deviations.
However, the consideration of the mean alone is not enough. The standard deviation
within the classes should also be taken into account because in some cases the
difference between the means is high, but the data of each group are scattered and
highly overlapping (Figure 2.7). Fisher [43] proposed a solution to this problem
that maximize the difference between the means normalized by a measure of the
within-class scatter. The variance of each class can be defined as the following:
s˜2i =
∑
y∈ci
(y − µ˜i)2, (2.15)
where the quantity (s˜21 + s˜
2
2) is called the within-class scatter of the projected data.
The linear discriminant is defined as the linear function wTx that maximizes the
following criterion function:
J(w) =
|µ˜1 − µ˜2|2
s˜21 + s˜
2
2
. (2.16)
We find a projection where the samples in the same class are close together and
the projected means are the furthest apart from one another. To find the optimal
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projection w, the explicit form of w from the J(w) needs to be expressed. In the
scatter of the multivariable feature space x, the scatter measurements are given by
the following scatter matrices:
Si =
∑
x∈ci
(x− µi)(x− µi)T. (2.17)
In the two-class classification, we defined the within-class scatter matrix Sw where
the Sw = S1 + S2. The scatter of the projection y can then be determined in a
function of the scatter matrix in the feature space x:
s˜2i =
∑
y∈ci
(y − µ˜i)2 =
∑
x∈ci
(wTx−wTµi)2 =
∑
x∈ci
wT(x− µi)(x− µi)Tw = wTSiw.
(2.18)
Therefore, we obtain the following:
s˜21 + s˜
2
2 = w
TSWw. (2.19)
Similarly, the difference between the projected means can be expressed in terms of
the means in the feature space x as given by the following:
(µ˜1 − µ˜2)2 = (wTµ1 −wTµ2)2 = wT(µ1 − µ2)(µ1 − µ2)Tw = wTSBw, (2.20)
where SB is denoted as the between-class scatter. Notably, the rank of SB is at
most one because it is the outer product of two vectors. By substituting equation
(2.19) and equation (2.20) into equation (2.16), we obtain the Fisher criterion as
the following:
J(w) =
wTSBw
wTSWw
. (2.21)
To find the maximum of J(w), we compute the derivative of J(w) and set it equal
to zero:
d
dw
J(w) =
d
dw
(
wTSBw
wTSWw
)
= 0, (2.22)(
wTSWw
) d
dw
(
wTSBw
)− (wTSBw) d
dw
(
wTSWw
)
= 0,(
wTSWw
)
(2SBw)−
(
wTSBw
)
(2SWw) = 0,(
wTSWw
wTSWw
)
(SBw)−
(
wTSBw
wTSWw
)
(SWw) = 0,
SBw − λSWw = 0, where λ is a constant,
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S−1W SBw = λw. (2.23)
In this case, it is unnecessary to solve for the eigenvalues and eigenvectors of S−1W SB
because SBw = (µ1−µ2)(µ1−µ2)Tw = (µ1−µ2) ·k, where k is a constant, is always
in the direction of µ1−µ2 and the scale factor for w is unimportant [35]. Therefore,
the unscaled solution for the w that optimizes J(·) is w = S−1W (µ1 − µ2). Thus we
have obtained w for Fisher’s linear discriminant, which is the linear function that
produces the maximum ratio of between-class scatter to within-class scatter. The
classification has been converted from a d -dimensional problem to a one-dimensional
problem. We then find the threshold that is the point along the one-dimensional
subspace separating the projected points. The optimal decision boundary has the
equation wx + w0 = 0 where w = S
−1
W (µ1 − µ2) and w0 is a constant involving w
and the prior probabilities. The optimal decision rule is to decide data in c1 if the
linear discriminant exceeds some threshold, and to decide c2 otherwise.
2.2.3.2 Support Vector Machines
In the field of pattern recognition, the Support Vector Machines (SVMs) [16, 146]
have been widely used for classification purposes. SVMs are effective supervised
learning algorithms for finding an optimal hyperplane that separates the sample
classes of training data by maximizing the distance to the nearest training data
points. In the following, we briefly describe the basic concepts of SVMs.
Linear Support Vector Machine
We consider the linear separable binary classification or the separable case. For a
given l training samples with a dimensionality D, {xi, yi}, i = 1, ..., l where xi ∈ <D
and yi ∈ {−1, 1} are the respective classes, and we assume that the samples are
linearly separable. The separating hyperplane is defined by w · x + b = 0, where
w is the normal vector of the hyperplane and b/ ‖w‖ is the perpendicular distance
from the hyperplane to the origin. The support vectors are the data points closest
to the separating hyperplane and defined by the margin. The margin is given by the
two parallel hyperplanes H1,H2 with equal distance to the separating hyperplane
(Figure 2.8(a)). The aim of the SVM is to orientate this hyperplane to be furthest
from the closest samples of both classes, which maximizes the margin. Suppose that
all the training data satisfy the following constraints:
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(a) (b)
Figure 2.8: Linear separation in a two-dimensional feature space. (a) The SVM
attempts to find an optimal linear hyperplane by maximizing the margin. The
dashed lines are the margins chosen with the closest data points to the line. The data
points that constrain the width of the margins are called the support vectors. For
the (b) non-separable case of the SVM, the constraint is relaxed by the introduction
of a slack variable.
xi ·w + b ≥ +1 for yi = +1 (2.24)
xi ·w + b ≤ −1 for yi = −1. (2.25)
These inequalities can then be combined into the following:
y i(xi ·w + b)− 1 ≥ 0, ∀ i and yi ∈ {−1, 1}. (2.26)
The support vectors are then the data points lying on the following two hyperplanes:
H1 : xi ·w + b = 1
H2 : xi ·w + b = −1
(2.27)
which the margin is defined as the distance between these two hyperplanes. We
calculate the margin by subtracting the perpendicular distance of H2 to the origin
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(|−b+1|/ ‖w‖) from the perpendicular distance of H1 to the origin (|−b−1|/ ‖w‖).
Hence, the margin is simply 2/ ‖w‖. Thus, we find the pair of hyperplanes that give
the maximum margin by minimizing ‖w‖ subject to the constraints of equation
(2.26). To avoid the square root in the norm and allow Quadratic Programming
(QP) to be used later on, we minimize 1
2
‖w‖2, which is equivalent to minimizing
‖w‖. We therefore need to solve the following:
min
1
2
‖w‖2 ,
subject to yi(xi ·w + b)− 1 ≥ 0, ∀ i.
(2.28)
The method of Lagrange multipliers can be used to find the minima of this objective
function subject to the constraint. The Lagrange multipliers, αi ≥ 0, i = 1, . . . , l,
are introduced. The Lagrangian is the following:
LP =
1
2
‖w‖2 −
l∑
i=1
αi [yi(xi ·w + b)− 1]
=
1
2
‖w‖2 −
l∑
i=1
αiyixi ·w − b
l∑
i=1
αiyi +
l∑
i=1
αi, αi ≥ 0, ∀i. (2.29)
We then compute the partial derivatives ∂
∂w
Lp and
∂
∂b
Lp and set them equal to zero:
∂
∂w
LP = 0 ⇒ w =
l∑
i=1
αiyixi, (2.30)
∂
∂b
LP = 0 ⇒
l∑
i=1
αiyi = 0. (2.31)
By substituting equation (2.30) and equation (2.31) into equation (2.29), we find
the following:
LD =
l∑
i=1
αi − 1
2
l∑
i=1
l∑
j=1
αiαjyiyjx
T
i xj, (2.32)
subject to αi ≥ 0, ∀i and
l∑
i=1
αiyi = 0.
This LD is referred to as the dual form of the primary LP . Note that LD only
depends on the Lagrange multiplier α (not on w and b); in LD, the training data
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appear as the dot products (xTi xj), and this property can be exploited to perform
the classification in a higher dimensional space. For the training of the SVM, we
maximize LD with respect to αi and subject to the constraints of equation (2.31)
and the positivity of the α as shown in equation (2.32). w is then given by equation
(2.30), and b is determined with the complementary condition of the Karush-Kuhn-
Tucker (KKT) conditions for the primal problem LP :
αi [yi(xi ·w + b)− 1] = 0, ∀i. (2.33)
The complementary condition of the KKT is applied to all samples in the training
set. Therefore, for each sample, either αi = 0 or (yi(xi · w + b) − 1) = 0 must be
hold. Those sample points for which αi > 0 are then found on one of the hyperplanes
which are the support vectors. For all other training samples αi = 0.
The sample point, which is a support vector (xs), will have the following form:
ys(xs ·w + b) = 1. (2.34)
We substitute equation (2.30) into equation (2.34) and find the following:
ys(
∑
m∈S
αmymxm · xs + b) = 1 (2.35)
where S denotes the set of indices of the support vectors. S is determined by finding
the indices i where αi > 0. We then multiply through by ys when y
2
s = 1. Therefore,
we get b from the following:
y2s(
∑
m∈S
αmymxm · xs + b) = ys ⇒ b = ys −
∑
m∈S
αmymxm · xs. (2.36)
Instead of using an arbitrary support vector xs, it is more advantageous to take an
average of all of the support vectors in S :
b =
1
Ns
∑
s∈S
(ys −
∑
m∈S
αmymxm · xs). (2.37)
To apply the trained SVM for the classification of a test sample xt, we applied the
following hyperplane decision function:
f(xt) = sign(w · xt + b). (2.38)
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For the binary classification of the data that is not fully linearly separable or the
non-separable case, the constraints of equation (2.26) are relaxed to allow for
misclassification of the samples by the introduction of a positive slack variable,
ξi, i = 1, . . . , l (Figure 2.8(b)) as follows:
yi(xi ·w + b) ≥ 1− ξi, ∀i,
ξi ≥ 0, ∀i.
(2.39)
These slack variables measure the deviation from the ideal conditions. For 0 ≤ ξi ≤
1, the data point falls inside the region of separation but on the right side of the
decision surface. For ξi > 1, the data point falls on the wrong side of the separating
hyperplane. The sum of the slack variables
∑
i ξi provides an upper bound on the
number of training errors. The objective function can be formulated in the relaxed
version as 1
2
‖w‖2 +C∑i ξi, where the parameter C regulates the penalty of errors
and has to be chosen by the user. This formulation is called a soft margin classifier.
Formulating the primal problem by applying the Lagrange multipliers αi and µi
yields the following:
LP =
1
2
‖w‖2 + C
∑
i
ξi −
∑
i
αi{yi(xi ·w + b)− 1 + ξi} −
∑
i
µiξi (2.40)
where µi is introduced to enforce the inequality ξi ≥ 0. Differentiating with respect
to w, b and ξi and setting the derivatives to zero:
∂
∂w
LP = 0 ⇒ w =
l∑
i=1
αiyixi, (2.41)
∂
∂b
LP = 0 ⇒
l∑
i=1
αiyi = 0, (2.42)
∂
∂ξi
LP = 0 ⇒ C = αi + µi. (2.43)
The substitution of these formulations into equation (2.40) gives the formulation of
the dual problem LD, which is the same for the separable case. The only difference
is that there is an additional constraint 0 ≤ αi ≤ C, ∀i, which means that there
exists an upper bound C on the αi in this non-separable case. b is then calculated in
the same way as the separable case with the KKT conditions of the primal problem:
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αi [yi(xi ·w + b)− 1 + ξi] = 0 and µiξi = 0. (2.44)
Non-linear Support Vector Machine
The generalization of the above formulations with the non-linear decision function
is straightforward. The training samples are mapped to a higher dimensional Eu-
clidean space H by a non-linear feature mapping function Φ. The mapping is per-
formed in accordance with Cover’s theorem, which the data in mapped space are
linearly separable. For the training of the SVM equation (2.32), the training data
only appear in a dot product xi · xj. Thus, for the data transformed to H, the
machine handles only the dot product of the mapping Φ(xi) · Φ(xj). If there ex-
ists a kernel function K(xi,xj) = Φ(xi) · Φ(xj), we do not have to consider the
explicit form of Φ, but could only use K(xi,xj) instead of using the dot product
Φ(xi) ·Φ(xj) in equation (2.32). Thus, the SVM performs a linear separation of the
data in H corresponding to a non-linear separation in the lower dimensional original
space with the following:
LD =
l∑
i=1
αi − 1
2
l∑
i=1
l∑
j=1
αiαjyiyjK(xi,xj) (2.45)
There exist kernel functions with the property K(xi,xj) = Φ(xi) · Φ(xj) if
they satisfy Mercer ’s condition: for any g(x) such that
∫
g(x)2dx is finite, then∫
K(x,y)g(x)g(y)dxdy ≥ 0. This condition only examines whether a kernel is an
inner-product kernel in some space, but it does not tell us how to construct the
mapping function Φ. We used the Gaussian radial basis function kernel in our anal-
ysis because it has been shown to work very well for the classification of cell images
in previous analyses [27, 55].
2.2.4 Image features for the classification of cells
To analyze images of the siRNA screens, an automated system, which was described
in detail recently [55, 56, 57], was employed. Briefly, a quadratic sliding window was
used to calculate local thresholds for different image regions. The local threshold was
only calculated if the variance within the window reached a pre-defined threshold
(2000); otherwise, a global threshold was used. The window consisted of an outer
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region of 15 pixels in which the thresholds were computed and an inner region of
2 pixels in which the thresholds were applied. The window was shifted by the
length of its inner region. The global and local thresholds were calculated using the
Otsu thresholding method. After segmentation, the following quantitative image
features were extracted from the image for each single cell: granularity features,
object- and edge-related features, tree-structured wavelet features, Haralick texture
features, grey-scale invariants and Zernike moments. In total, we computed 353
features for each cell nucleus. Using these features, the single-cell images were
classified into the following classes: interphase, mitosis, apoptosis and cell clusters.
The Haralick features have relatively high computational costs. It would have taken
several weeks or months to compute the Haralick texture features from all the image
data; therefore, my colleagues, M.Gipp, G.Marcus and R.Ma¨nner, and us employed
the general-purpose graphics processing units (GPUs) to speed up the computation
of the co-occurrence matrices and Haralick texture features. A massive parallel
software version for the GPUs was designed and implemented for this purpose. The
computational time was shortened by a factor of 32 on a single node of a cluster in
comparison to a pre-existing optimized CPU software version [47].
We extracted a set of image features for each single cell. Table 2.2 illustrates the
number of extracted features. All these features were described in detail in Harder
et al. [55, 56, 57]; I briefly describe them below.
Haralick texture features: The Haralick texture features [53] are the most im-
portant features and have been widely used to describe the characteristics of a cell
image in several research reports [28, 45, 55, 98]; these features are also included in
several cell analysis software packages [29, 64, 103]. The Haralick texture features
are based on the co-occurrence matrices of an image. A co-occurrence matrix (C ) is
computed by the relative frequencies of all occurring gray value pairs of pixels at a
given distance d with the angle φ, C (d, φ). The co-occurrence matrix for an image
with gray values in the range of [0, Ng-1] is defined as the following:
C(d, φ) =

P (0, 0) P (0, 1) . . . P (0, Ng − 1)
P (1, 0) P (1, 1) . . . P (1, Ng − 1)
...
...
. . .
...
P (Ng − 1, 0) P (Ng − 1, 1) . . . P (Ng − 1, Ng − 1)
 , (2.46)
where P (gi, gj) =
1
R
η(gi, gj) is the probability for a gray value pair (gi, gj), η(gi, gj) is
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Table 2.2: Sets of features extracted from each single cell.
Feature set Total
number
Haralick texture 260
Zernike moments 49
Granularity 21
Object-related 8
Edge-related 3
Gray scale invariants 10
Tree-structured wavelets 2
the frequency of a gray value pair (gi, gj) and R is the total number of possible pixel
pairs in the image depending on d and φ. In this work, we compute co-occurrence
matrices for the distances of one to five pixels and angles of 0◦, 45◦, 90◦, and 135◦.
Thirteen statistical features (e.g., the angular second moment, contrast, correlation,
variance, and entropy) are computed for each co-occurrence matrix, which leads
to 260 image features that describe the texture of an image. Table 2.3 lists the
thirteen features.
Object- and edge-related features: For the object- and edge-related features,
the basic attributes of an object, such as the area (number of pixels), contour length
(perimeter), and moments (e.g., the mean gray value and standard deviation of the
gray value), are measured. The circularity of an object is computed by p
2
A
, where
p is the perimeter of an object and A is the area of the object. Feret’s distance,
which is the longest distance within an area, is computed using the greatest possible
distance between any two contour pixels. The edge-related features are computed
by applying the Laplace and Sobel filters to the image and refining the detected
edges with a thresholding method. The number of detected edge pixels is used as a
further feature.
Granularity features: The granularity features depend on the relation of neigh-
boring pixel pairs. The differences in the gray levels of the center pixel and all
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Table 2.3: Thirteen statistical features computed on a co-occurrence matrix.
Angular second moment f1 =
∑
i
∑
j(P (i, j))
2
Contrast f2 =
∑Ng−1
n=0 n
2
{∑
i
∑
j P (i, j)
}
, |i− j| = n
Correlation f3 =
[
∑
i
∑
j(ij)P (i,j)]−µxµy
σxσy
Variance f4 =
∑
i
∑
j(i− µ)2P (i, j)
Inverse difference moment f5 =
∑
i
∑
j
P (i,j)
1+(i−j)2
Sum average f6 =
∑2Ng−2
i=0 iPx+y(i)
Sum variance f7 =
∑2Ng−2
i=0 (i− f6)2Px+y(i)
Sum entropy f8 = −
∑2Ng−2
i=0 Px+y(i) logPx+y(i)
Entropy f9 = −
∑
i
∑
j P (i, j) logP (i, j)
Difference variance f10 =
∑Ng−1
i=0 i
2Px−y(i)
Difference entropy f11 = −
∑Ng−1
i=0 Px−y(i) logPx−y(i)
Information measure I f12 =
Hxy−H1xy
max{Hx,Hy}
Information measure II f13 =
√
1− exp(−2(H2xy −Hxy))
Definition:
H1xy = −
∑
i
∑
j P (i, j) log(Px(i)Py(j))
H2xy = −
∑
i
∑
j Px(i)Py(j) log(Px(i)Py(j))
Px(i) =
∑
j P (i, j), Py(i) =
∑
i P (i, j)
Px±y(k) =
∑
i
∑
j,|i±j|=k P (i, j)
µ, µx, µy;σx, σy;Hx, Hy are the means and standard deviations and entropies.
pixels within a given distance (e.g., 1-10 pixels) in eight directions (0◦, 45◦, 90◦,
135◦, 180◦, 225◦, 270◦, and 315◦) are computed, and the maximum difference in
each direction is stored. The mean and standard deviation of the maxima over all
image pixels are computed.
Gray scale invariant features: The gray scale invariant features [17] are com-
puted by combining a pair of neighboring pixels in an image g(x, y) using a
simple nonlinear kernel function f that transforms the gray value into form of
f(g(x, y)) = f1(g(x, y)) · f2(g(x + d1, y + d2)), where d = [d1, d2] is a span vector
for the kernel function. This function is computed for each pixel and its neighbors
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in all possible directions. The summation of the resulting values yields a value
being invariant to rotation. This strategy is applied to all possible positions in
the image, and the results are summed for the whole image, which yields a value
that is invariant to rotation of the image content. The applied kernel functions are
the followings: (1) the product of the gray values (f1(g) = f2(g) = g) and (2) the
product of the square roots of the gray value (f1(g) = f2(g) =
√
g). Different grey
scale invariant features are computed by varying the distances (i.e., the distances
between the center and neighboring pixels).
Zernike moment features: These moments are commonly used to character-
ize distributions. In image processing, an image region is considered as a two-
dimensional density function. The moment sets of different orders and with a differ-
ent basis function can be used to describe the information in an image region [111].
The complex Zernike moments [165] use a set of complex polynomials that form a
complete orthogonal basis that is defined over a unit circle. The image is translated
and scaled to a unit disc first (disc centered at the origin (0,0) with radius one) be-
cause these Zernike polynomials defined within a unit circle. For an image g(x, y),
the Zernike moments can be computed using the following:
Zmn =
m+ 1
pi
Nx−1∑
x=0
Ny−1∑
y=0
V ∗mn(x, y)g(x, y), (2.47)
where x2 + y2 ≤ 1 and V ∗mn(x, y) is the complex conjugate of a Zernike polynomial
of the degree m, n is a positive integer with 0 ≤ n ≤ m and m-n is even, and
Vmn(x, y) =
(m−n)/2∑
s=0
(−1)s (m− s)!
s!
[
m+n
2
− s] ! [m−n
2
− s] ! · (x2 + y2)m2 −s exp(ynθ) (2.48)
where θ = tan−1(y/x), and y =
√−1. As proposed by Boland et al. [10], the mag-
nitudes |Zmn| of the moment are used as image features. The Zernike moments are
calculated up to degree 12 (m ≤ 12) and all possible values for n; this calculation
results in 49 features.
Tree-structured wavelets: A wavelet transform decomposes a signal into differ-
ent frequency channels. Applying a wavelet transform to a 2D input image yields
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four subimages. Each subimage comprises a part of the whole frequency band-
width and has a quarter of the input image resolution. Daubechies wavelets [30]
are widely used in signal and image processing. The decomposition is based on
12-tab Daubechies wavelets. Tree-structured wavelet transform [21] is a multireso-
lution analysis approach. This approach decomposes only the significant frequency
channels of the subimages, that contain the most information. The information con-
tent is determined using the image energy. The image energy is computed from an
energy function E (g) for an image g(x,y) with x- and y-dimensions Nx, Ny, which
is the mean of the absolute gray values given by the following:
E(g) =
1
NxNy
Nx−1∑
x=0
Ny−1∑
y=0
|g(x, y)| . (2.49)
The decomposition is recursively performed on the input image depending on the
image size. At each decomposition step, the feature used is a product of the highest
energy value and a constant representing the frequency channel in which the highest
energy was observed.
2.2.5 Pairwise phenotypic descriptors for protein-protein
interactions
The fraction and maxima features
As mentioned in Section 2.2.4, the segmentation and feature extraction were per-
formed using an automated image processing system as described in [55]. Each
single cell nuclei was segmented using the Otsu thresholding method and charac-
terized using morphological descriptors (Table 2.2) such as the Haralick texture,
Zernike moment, granularity features, object-and edge-related features, grey-scale
invariants, number of cells and pixels. These features were used to distinguish be-
tween different phenotypes of the cells. Using SVM analysis (Section 2.2.3.2), each
single cell was classified into the following four morphological classes: interphase,
apoptosis, mitosis, and shape (cluster of cells). The classifier was trained to distin-
guish between the four phenotypic classes using the trained morphological classes
that were manually annotated by an expert. The fractions of each phenotype were
computed with respect to the number of cells in an image for each knocked-down
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gene. The features of cell proliferation, median and standard deviation of the cellu-
lar intensities, were also calculated. To obtain features for a pair of knocked-down
genes, we calculated the absolute value of the differences between the features for
each gene of the respective pair. These features were termed “fraction features”.
To obtain more discriminative features, we used features from the original study
by Neumann and co-workers [98]. The phenotypic scores of the seven morphological
phenotypes from the Mitocheck database (www.mitocheck.org) were extracted and
comprised the following features: 1) mitotic delay, 2) binuclear, 3) polylobed, 4)
grape, 5) large, 6) dynamic change, and 7) cell death. The scores were derived from
the maximum difference of the cell counts between the negative controls and the
cells of the respective class (of one of the seven morphological phenotypes). The
time points for these maxima were also taken as features. We also calculated the
absolute value of the differences between the features for each gene of the respective
pair to obtain features for a pair of knocked-down genes. These features were
termed “maxima features”.
LDA-Similarity and proximity features
We used linear discriminant analysis (LDA) (Section 2.2.3.1) to distinguish between
two sets of single cells in which each set of cells had a different gene knocked down.
These features were termed LDA-performance features. If two sets of single cells
were classified well (i.e., the phenotypes that resulted from the knockdown of the
corresponding two genes were dissimilar), then these sets yielded a favorable dis-
crimination performance. The performance (accuracy) of the classification was used
as a similarity feature. For the proximity-features, we computed the distances be-
tween a reference gene and two genes instead of computing the distance between
two genes directly; we then computed the difference of these two distance vectors.
If these two genes are close together, these two distances should also be close to-
gether. These proximity features were computed with 5 reference genes to find a
vector of the distance. To obtain different feature vectors, we selected 5 reference
genes that are distinct from each other. An integer linear programming problem
was formulated for finding these reference genes.
The LDA-performance feature and the Euclidean distance of maxima features
were used as distances. For all genes, the distance of a gene to the other genes was
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computed. The problem of finding k genes that were distant from each others can
be formulated as the following quadratic problem:
max
∑
dijxixj,
subject to:
∑
i
xi ≤ k,
xi, xj ∈ {0, 1} ,
i, j = 1, . . . N,
(2.50)
where dij is the distance from gene xi to gene xj. However, this problem can be
transformed into an integer linear problem. We introduced a new variable yij, which
can be represented as yij = xixj. The integer linear problem is defined as the
following:
max
∑
dijyij
subject to: (I) yij ≤ xi,
(II) yij ≤ xj,
(III) yij ≥ xi + xj − 1,
(IV)
∑
i
xi ≤ k,
xi ∈ {0, 1} , yij ∈ {0, 1} ,
∀i, j ∈ {1, . . . , N}, i < j.
(2.51)
In this maximization case, the constraint (III) can be discarded. To reduce the
complexity of the problem, thirty genes with distances that deviated significantly
were selected. In this study, we performed computations to obtain five optimal genes
(k=5). To find the difference between the distances of optimal gene pairs and other
gene pairs, the distances were normalized for values in a range from 0 to 1, and
the distances of all combination of each sets were computed. When computations
were performed using the LDA-performance and maxima features as the distances,
the distances of all combinations of optimal gene pairs yielded significantly higher
values than the distance of all combinations of other gene pairs (Figure 2.9).
In summary, the pairwise phenotypic features are comprised of the following
sets of fraction features, LDA-performance feature, maxima features, and proxim-
ity features. The complete list of pairwise phenotypic features is shown in Table 2.4.
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Figure 2.9: Comparison of the distances between all combinations of the optimal
genes and all combinations of the other genes. The P -values were calculated for the
two distributions of distances between the five optimal genes and the other genes
using a Wilcoxon test.
Table 2.4: Pairwise phenotypic descriptors
Feature name Description
Fraction features
frApop Distance computed from the fractions of Apoptotic cells
frInter Distance computed from the fractions of Interphase cells
frMito Distance computed from the fractions of Mitosis cells
frShape Distance computed from the fractions of Cluster cells
medMean Distance computed from the medians of mean of cell intensities
medSD Distance computed from the medians of standard deviation of cell
intensities
medNbPixel Distance computed from the medians of number of cell images
pixels
medNumCell Distance computed from the medians of number of cells
ProliferRate Distance computed from the cell proliferation rates
Continued on next page...
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Table 2.4 – continued from previous page
Feature name Description
LDA-performance feature
LDA-performance LDA similarity
Maxima features
MitoticDelay Distance computed from the maximum scores of a Mitotic Delay
phenotype
Binuclear Distance computed from the maximum scores of a Binuclear phe-
notype
Polylobed Distance computed from the maximum scores of a Polylobed phe-
notype
Grape Distance computed from the maximum scores of a Grape pheno-
type
Large Distance computed from the maximum scores of a Large pheno-
type
DynamicChange Distance computed from the maximum scores of a Dynamic
Change phenotype
CellDeath Distance computed from the maximum scores of a Cell death phe-
notype
tMitoticDelay Distance computed from the time point with the max.score of a
Mitotic Delay phenotype
tBinuclear Distance computed from the time point with the max.score of a
Binuclear phenotype
tPolylobed Distance computed from the time point with the max.score of a
Polylobed phenotype
tGrape Distance computed from the time point with the max.score of a
Grape phenotype
tLarge Distance computed from the time point with the max.score of a
Large phenotype
tDynamicChange Distance computed from the time point with the max.score of a
Dynamic Change phenotype
tCellDeath Distance computed from the time point with the max.score of a
Cell death phenotype
Proximity features
SpScoreRef(1-5) Distance computed from reference gene(1-5) using the maxima
features
LDAperfRef(1-5) Distance computed from reference gene(1-5) using the LDA-
performance
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Figure 2.10: Two nested cross-validation loop. The 10-times 10-fold cross-validation
technique was performed with a 5-times 5-fold cross-validation for parameter opti-
mization.
2.2.6 Classification of interactions with a role in the activa-
tion or inhibition of signal transduction
Based on the pairwise phenotypic descriptors, we classified the interactions as hav-
ing a role in the activation or inhibition of signal transduction using the SVM as
mentioned in Section 2.2.3.2. To assess the performance of the classifiers, 10-times-
10-fold cross-validations were performed (Figure 2.10). In each cross-validation, the
PPIs involved in the activation and inhibition of signal transduction were randomly
split into ten equally sized, non-overlapping subsets. The nine subsets were concate-
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nated and used for training the classifiers and testing of the one remaining subset.
The performance was measured on the test set by comparing the predictions with
the true class labels. To measure the performance of the predictions of the PPIs
involved in the activation of signal transduction, these PPIs were set as the posi-
tives. This process was repeated ten times until each subset was tested once. In our
dataset, the sizes of the two classes (Act-PPI and Inh-PPI) differed considerably.
Therefore, a data stratification was performed using an ensemble machine learning
technique. In each training subset, ten SVM classifiers were trained with equal
stratified numbers of randomly selected PPIs that are involved in the activation and
inhibition of signal transduction.
To optimize parameters for the classifiers, the nested cross-validation loops were
employed. In the inner loop, the cross-validations were repeated to obtain the opti-
mal parameter set (Figure 2.10). It is crucial that the test data were not included in
this inner cross-validation. For each combination of parameters used for the training
step, the cross-validation performance was measured, and the significant parameters
were selected in this inner loop. In this work, we used a radial basis function as a
kernel for our SVM. Therefore, there are two parameters for the optimization of the
kernel (Section 2.2.7). To obtain the overall performance of the classifiers from the
nested cross-validation loops, we repeated the cross-validation procedure 10 times.
The votes of each testing sample were summed from the predictions of the classifiers
for a certain class. Using these votes, a receiver operator characteristics curve (ROC
curve) was used to measure the performance of the classifiers (Section 2.2.8). The
performance was estimated by the area under the curve (AUC) for the entire range
of thresholds based on the votes. To predict new interactions, all 1000 trained clas-
sifiers were employed as an ensemble classifier that used a voting scheme in which
each SVM contributed one vote. Figure 2.10 shows the cross-validation procedure
with a 10-fold cross-validation for the outer loop and a 5-fold cross-validation for the
inner loop. The software library LIBSVM [20] was used for the SVM classifications.
2.2.7 Parameter optimization and voting scheme technique
The SVM algorithm (Section 2.2.3.2) was employed for the classification. Using a
radial basis kernel, there are two SVM parameters that can be optimized: 1) the
regularization term that defined the costs of false classification (C ); and 2) kernel
width parameter (γ), which regulates the variance of the kernel. Using an approach
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proposed by Hsu et al. [59], we performed a grid search on the training data to
maximize the classification accuracy on a defined parameter space. The parameter
space was defined using the value of C and γ, which grow exponentially (C =
2n, γ = 2n, n = -5, -4,. . . , 4, 5). To measure the classification performance, we
split the training data into two parts. One part is used for the training data (also
called the training set) that is used to train the classifier. The other part is called
a test set and is used for the testing of the trained classifier. The classification
performance is measured on the test set by comparing the classifier output with
the true classes of the test set. Then, the percentage of correct classifications can
be determined. However, training and testing the data on a training set might not
reflect the true classification performance and produce poor classification results for
other data because of the use of a specific training set. To achieve more reliable
results, the parameter testing can be performed on several independent data sets
using the cross-validation technique. In this work, we used a 5-fold cross-validation
for the parameter optimization (Figure 2.10). The cross-validation technique splits
the data into 5 subsets of equal size. Four of the subsets were used for training the
classifier and the other subset is used to test the classifier. This process is repeated
5 times until each subset has been tested once. The best determined combination
of the C and γ can be used for the whole training set to train the final classifier.
2.2.8 Performance measurements
By comparing the predictions with the true classes, we can generate a confusion
matrix, which is also called contingency table. Table 2.5 shows an example of a
confusion matrix of a two-class classification task. TP are the true positives, FN
are the false negatives, FP are the false positives, and TN are the true negatives.
Accuracy is a commonly used classification measurement. The accuracy measures
the proportion of correct predictions:
accuracy =
TP + TN
TP + FN + FP + TN
. (2.52)
From the confusion matrix, we can compute other performance values such as the
sensitivity, specificity, positive predictive value and negative predictive value. The
sensitivity or recall is the proportion of actual positives that are correctly classified,
whereas the specificity is the proportion of negatives that are correctly classified.
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Table 2.5: Confusion matrix of the two-class classification
Predicted Classes
Positive Negative
True Classes
Positive TP FN
Negative FP TN
The positive predictive value or precision rate measures the proportion of correct
positive predictions performed by a classifier, whereas the negative predictive pre-
diction denotes the portion of correct negative predictions:
sensitivity =
TP
TP + FN
, (2.53)
specificity =
TN
TN + FP
, (2.54)
positive predictive value =
TP
TP + FP
, (2.55)
negative predictive value =
TN
TN + FN
. (2.56)
These performance measures resulted from a dataset that is called a test set.
The test set with known class labels is the data remaining after the data of the
training set is removed. We perform the measurement on the test set instead of the
training set to avoid the overestimation the measurement. The test set is applied
to the trained classifier and predicts the class labels. The predicted labels are then
compared with the true labels and the performance measurements are calculated as
described above.
Receiver operator characteristics and the area under the ROC curve
A common approach used to compute the overall classification performance is the
receiver operator characteristic (ROC) curve and the area under the ROC curve
(AUC). The ROC is suitable for measuring the performance of a classifier system
using various thresholds of stringency (e.g., when using voting scheme technique).
The ROC curve shows the true positive rate (sensitivity) versus the false positive
rate (1-specificity). The overall performance of the classifiers is calculated from the
area under the ROC curve. A perfect classifier has an AUC of 1.0, whereas random
guessing produces an AUC of 0.5. Figure 2.11 ROCs shows an example of an ROC
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Figure 2.11: An example of an ROC curve. The performance of multiple thresholds
can easily be investigated by plotting. For example, a certain threshold at point
A yields a sensitivity of 0.8 and a specificity of 0.7. Another threshold at point B
yields a sensitivity of 0.7 and a specificity of 0.8.
curve.
By changing the thresholds, we determined a point on the ROC curve. From the
example curve of Figure 2.11, we found the point A using a certain threshold. At
this point, we found a sensitivity value of 0.8 and a specificity value of 0.7. Using a
different threshold, we found the point B, which has a sensitivity value of 0.7 and
a higher specificity value of 0.8. The dashed diagonal line represents the results
from random predictions that produce an AUC of 0.5. The perfect classifier yields a
curve that includes the coordinate (0,1) in the upper left corner, which corresponds
to 100% sensitivity, 100% specificity and an AUC that is equal to one.
2.2.9 Consistency score
To improve the precision of classification performance, we conducted a statistical
post-processing step that was used to filter our results. We compared the effect of
each of the down-regulated genes of a pair (genei, genej) to all other investigated
genes (genek). If both knocked-down genes (i.e., the gene i and j) showed the same
58 Methods
prediction to the other gene k, we defined the knocked-down genes as interacting
“consistently” with respect to genek. Similarly, if one of them showed a prediction
of activation and the other inhibition, we set that pair to be inconsistent with
respect to genek. This was performed for all other genes k, k ∈ {all genes \{i, j}},
and the portion of consistent and inconsistent interactions was used to define the
consistency score (high consistency = a higher number of other genes that show
the same activation/inhibition predictions to both genes of the pair). This criterion
was used to filter out gene pairs that had a high consistency but a low number
of votes used for the prediction of a PPI as involved in the activation of signal
transduction (and vice versa for inhibition). If the voting score of a gene pair was
less than 100, it was predicted to be a PPI that is involved in the inhibition of signal
transduction; In turn, if the vote of a pair was more than 900, it was defined as a
potential PPI that is involved in the activation of signal transduction. All other
predictions were assigned as undefined. We computed the consistency score from
the percentage of consistency and inconsistency values. To quantify the difference
between the consistency and inconsistency values, we calculated the similarity score
by transforming the percentage of consistency and inconsistency values into the
range between -1 and 1 using the following hyperbolic tangent function:
f(x) = tanh(k ∗X), (2.57)
where X is the proportion of consistency values subtracted by the proportion of
inconsistency values. For this study, we used the optimized parameter k=5 and we
improved the negative (or lower than average) and positive (or higher than average)
consistency scores to yield the PPIs as involved in the inhibition and activation,
respectively, of signal transduction.
2.2.10 Enrichment tests for the consistency score of protein
pairs
All protein pairs and their consistency score (gpi, i=1,. . . , all protein pairs)
were investigated using the interaction databases, STRING version 9.0 [136] and
MetaCoreTM version 6.8, www.genego.com. We applied the gene set enrichment
analysis (GSEA) strategy of Subramanian et al. [131]. The goal of GSEA is to de-
termine whether the evidenced interactions (a list S with NH pairs in the database)
are randomly distributed throughout our ranked consistency scores r(gpj) = rj in a
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list L = {gp1, gp2, ..., gpN} or found at the top or bottom of the list. This approach is
essentially a Kolmogorov-Smirnov test of running sums over the ranked scores. The
enrichment score (ES ) was computed and indicated the degree of overrepresentation
of a set S in the top or bottom of the ranked list L. The algorithm walks into the
ranked list L, and a running-sum is increased if the gene pairs found in the list S, are
also found in the database; otherwise, the running-sum is decreased. The maximum
deviation between the zero encountered in the random walk and the magnitude of
the increment was calculated as the ES. The ES is calculated as follows:
ES(S) = max
1≤i≤N

∑
gpj∈S
j≤i
1
NR
−
∑
gpj /∈S
j≤i
1
N −NR
 (2.58)
where NR is the number of gpj ∈ S. The ES is the fraction of interaction pairs in S
running up to i, and the value is penalized by the fraction of the interaction pairs not
in S running up to i. To assess the significance of the ES, we compared the observed
ES with the null set of ES scores that were computed using a permutation-based
approach. We found the null distribution of the permutated ES by permuting the
interaction pair labels and re-computing the ES(S). We repeated this step 104 per-
mutation times and computed the nominal P -value for S from the null distribution.
The nominal P -value is estimated as the portion of the permutated ES which is
greater than the observed ES.
Chapter 3
Results
This chapter describes our results mainly consisting of two parts. Section 3.1 de-
scribes the results of clustering of cells infected with Hepatitis C Virus to iden-
tify host factors. Section 3.2 presents the results of characterizing the activities of
protein-protein interactions using machine learning approaches.
3.1 Clustering of cells infected with Hepatitis C
Virus
Viruses can spread within a host through the release of cell-free virions or direct
passage between infected and non-infected cells. In general, direct cell-cell transfer
is considerably more efficient than cell-free transfer [141] and can be supported by
filopodial bridges [124], virological synapses, or nanotubes [120]. As a consequence
of such a viral cell–cell spreading, clusters of infected cells may be formed. It was
recently reported that the spatial distribution of cells can influence infection behav-
ior. Snijder and co-workers observed intriguing relationships between virus species,
the spatial distribution of cells and infection rates. While the infection efficiency
of a rotavirus was considerably increased in sparse populations, Dengue Viruses
mainly employed cells located at the edges of islets, and murine hepatitis viruses
were preferably found in dense cell populations [126]. To analyze such clustering
patterns systematically, statistical methods for point pattern analysis can be em-
ployed. Section 3.1.1 reports the parameter optimization of the clustering method
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and shows our hits compared with primary and secondary experimental screens.
Section 3.1.2 provides a functional interpretation of our hits. Section 3.1.3 provides
a comparison of the clustering behavior of cells infected with HCV and cells infected
with Dengue Virus.
3.1.1 Parameter optimization, choice of the most suitable
clustering analysis method and assembly of significant
hits
We identified cellular protein kinases involved in HCV replication by observing the
replication and clustering of infected cells upon silencing of protein kinases (2157
siRNAs targeted 719 human protein kinase genes). Virus-infected cells were identi-
fied through viral GFP expression observed using fluorescence microscopy analysis.
Host siRNA hits were identified based on three different approaches, (i) using the
viral GFP fluorescence intensity of the primary screen, (ii) the luciferase intensity
of the secondary screen and (iii) the clustering analysis method. In applying the
clustering analysis method, we computed a z -transformed clustering score for all
knockdowns. We analyzed the clustering of infected cells using the DAPI channel
(nucleus staining) to define the center of mass and the viral GFP signal for label-
Table 3.1: Pearson’s correlation coefficients for the intensity values of the scores
from K -function and the standard readouts (intensity values of the primary and
secondary screens).
K -function (Inho-
mogeneous)
K -function
(Homoge-
neous)
40% 35% 30% 25% 35%
Correlation with intensities of
the primary screen
0.51 0.55 0.49 0.36 0.36
Correlation with intensities of
the secondary screen
0.31 0.32 0.34 0.28 0.23
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(a) (b)
Figure 3.1: Images of positive (knockdown of CD81) and negative controls (non-
silencing siRNA). Knockdown of CD81 resulted in a rather random distribution of
infected cells (black dots), while infected cells were highly clustered when no genes
were silenced (unhindered viral replication).
ing the cells as infected and non-infected. Low clustering scores were yielded if the
infected cells did not cluster, while high values resulted specifically if the infected
cells showed high clustering. This trend is demonstrated exemplarily in Figure 3.1.
To detect the clustering we used K -function and optimized the performance
by varying the range of the radius. As the objective function, we analyzed the
correlation of the z -scores from K -function for all knocked-down genes with the
z -scores from the intensity readout of the primary screen and secondary screen.
Table 3.1 shows the obtained results. The best correlation with the primary screen
was 0.55 using a radius range of 35%.We investigated the performance of a well-
established clustering analysis method, Quadrat Analysis [156]. Quadrat Analysis
was tested, and the correlation with the primary and secondary experimental screens
was observed. We optimized the parameters for the Quadrat Analysis (QA, Section
2.1.4) by varying the number of rows (i) and columns (j ), with i = 3, 4, 5 and j = 4,
5, 6, yielding different grid sizes. Pearson’s correlation coefficients were computed
from VMR scores and intensity readout values from the primary and secondary
experimental screens. The results are presented in Table 3.2. However, the method
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Table 3.2: Pearson’s correlation coefficients for the intensity values of the Quadrat
Analysis and the standard readouts (intensity values of the primary and secondary
screens)
Quadrat Analysis
QA4x3 QA4x4 QA4x5
Correlation with intensities of the
primary screen
0.25 0.23 0.23
Correlation with intensities of the
secondary screen
-0.02 0.029 -0.027
QA5x3 QA5x4 QA5x5
Correlation with intensities of the
primary screen
0.23 0.23 0.22
Correlation with intensities of the
secondary screen
0.027 -0.0018 -0.033
QA6x3 QA6x4 QA6x5
Correlation with intensities of the
primary screen
0.22 0.20 0.19
Correlation with intensities of the
secondary screen
-0.07 -0.04 -0.097
showed less correlation with the intensity readouts (Table 3.2 shows the results for
several parameter settings).
Additionally, the homogeneous K -function was inferior to the inhomogenous K -
function (the result with the best radius range is given in Table 3.1). Here, we
report results using the inhomogenous K -function with the optimized parameter
(radius range = 35%). Knockdown of CD81 gene (positive control) resulted in low
clustering of the infected cells, while the negative control (non-silencing siRNAs)
showed a comparably high tendency for infected cells (black dots) to cluster. The
clustering scores were -2.3 and 2.2 for CD81 and the negative control, respectively.
In the primary screen, the mean intensities of viral GFP were calculated for each
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Figure 3.2: Comparison of the scores of the positive control (CD81) and the negative
controls (non-silencing siRNA) for all applied methods. The P -values were calcu-
lated for the two distributions of CD81 and the negative controls using Student’s
t-test.
knockdown and replicate (12 replicates), following which their z -scores were com-
puted with respect to the bulk of the data, and genes with significant low z -scores
were selected (P -value < 0.05). Significant genes were defined similarly based on the
secondary screen. The difference between the z -score distributions of the positive
control (CD81) and the negative controls is shown in Figure 3.2. The separation
of the distributions shows CD81 to be a significant down regulator in all three
approaches (i.e., primary screen, secondary screen and clustering analysis method).
The numbers of significant hits and their intersections are summarized in Figure 3.3.
Observation of viral signal intensities in the primary screen yielded 85 significant
genes. A total of 178 genes selected from the primary screen were observed with
the secondary screen yielding 64 significant genes. The clustering analysis method
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Figure 3.3: Venn diagram of the hits for all three applied methods.
yielded 30 genes (shown in Table 3.4). All three positive controls showed significantly
low clustering scores (CD81: P -value = 6.61E-07; HCV-321: P -value = 1.53E-13;
HCV-138: P -value = 1.20E-10). Five genes were found to be significant with all
three methods: CD81, PI4KA, CSNK2A1, SLAMF6 and FLT-4 (Table 3.3). Note
that the positive controls HCV-321 and HCV-138 were not used in the secondary
screen. CD81 was used as a positive control, as it is well-known viral receptor of
HCV [166] and is involved in HCV entry [114].
3.1.2 Functional interpretation of the results
In addition to CD81, we detected four host factors as significant using all
three analysis approaches (PI4KA, CSNK2A1, SLAMF-6 and FLT-4). Phos-
phatidylinositol 4-kinase-α (PI4KA) is well known to be required for HCV repli-
cation [5, 11, 77, 137, 142, 145]. It was shown in vitro that Casein kinase II (for
which CSNK2A1 encodes the subunit alpha) phosphorylates the non-structural HCV
protein NS5A [70]. Fms-related tyrosine kinase 4 (FLT-4), also known as vascular
endothelial growth factor receptor 3 (VEGFR-3), is a member of the tyrosine kinase
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Table 3.3: Host factors detected with all three analysis methods
Entrez
gene ID
Gene
symbol
Gene name P-value
(Clustering
method)
975 CD81 CD81 molecule 6.61E-07
5297 PI4KA Phosphatidylinositol 4-kinase,
catalytic, alpha
0.0019
1457 CSNK2A1 Casein kinase 2, alpha 1
polypeptide
0.0274
114836 SLAMF6 SLAM family member 6 0.0345
2324 FLT4 Fms-related tyrosine kinase-4 0.0445
receptor family. Over-expression of the short splice variant of VEGFR-3 stimulated
cell growth in HepG2 cells [79], which may favor infectious spreading of the virus.
Interestingly, a retrovirus was found to be integrated into an intron of FLT-4 in the
genome which may have resulted in an evolutionary advantage for this virus [61].
SLAMF-6 belongs to the signaling lymphocytic activation molecule family and is
a transmembrane receptor mainly expressed in natural killer (NKT) cells. This
receptor serves as a docking site for several signaling molecules [38, 147]. It was
shown that SLAMF-1 and SLAMF-6 critically control the characteristic expansion
and differentiation of NKT cells following thymic selection [49]. SLAMF-6 may be
a suitable interesting candidate for investigating the uptake and signal propagation
of the virus during its entry into the host cell.
3.1.3 Comparing the clustering behavior of HCV and the
Dengue Virus infection
The same experimental set-up as was used for HCV was applied to observe cells
infected with the Dengue Virus (DV) [92]. It is known that DV infects the edges
of islets of cell populations rather than forming clusters of infections [126]. We also
observed this behavior in our data which is shown exemplarily in Figure 3.4. We
compared the clustering scores for non-silencing siRNA images for both datasets and
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Table 3.4: The first 30 candidate genes from the clustering analysis approach.
Entrez
Gene
ID
Gene
Symbol
Gene Name P-Value Mean
Z -
score
HCV 321 Positive Control 1.53E-13 -2.9217
HCV 138 Positive Control 1.20E-10 -2.6395
975 CD81 CD81 molecule ( Positive Control) 6.61E-07 -2.1275
7852 CXCR4 Chemokine (C-X-C motif) receptor 4 6.14E-05 -0.6285
5297 PI4KA Phosphatidylinositol 4-kinase, catalytic, alpha 0.0019 -3.5111
4233 MET Met proto-oncogene (hepatocyte growth factor
receptor)
0.0030 -0.8307
10298 PAK4 p21 protein (Cdc42/Rac)-activated kinase 4 0.0041 -0.5306
51447 IP6K2 Inositol hexakisphosphate kinase 2 0.0061 -0.6380
10188 TNK2 Tyrosine kinase, non-receptor, 2 0.0072 -0.7748
9212 AURKB Aurora kinase B 0.0131 -0.5962
2645 GCK Glucokinase (hexokinase 4) 0.0175 -0.6753
5586 PKN2 Protein kinase N2 0.0193 -0.6841
140767 NRSN1 Neurensin 1 0.0197 -0.3436
440275 EIF2AK4 Eukaryotic translation initiation factor 2 alpha
kinase 4
0.0203 -0.7116
659 BMPR2 Bone morphogenetic protein receptor, type II
(serine/threonine kinase)
0.0238 -0.6405
5298 PI4KB Phosphatidylinositol 4-kinase, catalytic, beta 0.0259 -0.6006
6198 RPS6KB1 Ribosomal protein S6 kinase, 70kDa, polypep-
tide 1
0.0274 -0.5495
1457 CSNK2A1 Casein kinase 2, alpha 1 polypeptide 0.0274 -0.6259
255239 ANKK1 Ankyrin repeat and kinase domain containing
1
0.0323 -0.6443
5605 MAP2K2 Mitogen-activated protein kinase kinase 2 0.0328 -0.6364
132158 GLYCTK Glycerate kinase 0.0340 -0.5697
114836 SLAMF6 SLAM family member 6 0.0345 -0.4253
30849 PIK3R4 Phosphoinositide-3-kinase, regulatory subunit
4
0.0367 -0.9770
80216 ALPK1 Alpha-kinase 1 0.0408 -0.8162
51678 MPP6 Membrane protein, palmitoylated 6 (MAGUK
p55 subfamily member 6)
0.0413 -0.5960
130497 OSR1 Odd-skipped related 1 (Drosophila) 0.0434 -0.5213
2324 FLT4 fms-related tyrosine kinase 4 0.0445 -0.5479
10256 CNKSR1 Connector enhancer of kinase suppressor of
Ras 1
0.0448 -0.3241
5584 PRKCI Protein kinase C, iota 0.0449 -0.3953
548596 CKMT1A Creatine kinase, mitochondrial 1A 0.0463 -0.6092
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Figure 3.4: Left: Distribution of clustering scores for Hepatitis C Virus (HCV)
and Dengue Virus (DV). In comparison with DV, cells infected by HCV showed
significantly higher clustering scores (Wilcoxon test P=4.8E-04). Right: Typical
examples of real position images of infected (filled) and non-infected cells (not filled).
HCV infected cells show cluster formation, while DV infected cells populated rather
the edges of cell colonies.
observed significantly higher clustering scores for cells infected with HCV (Wilcoxon
test P= 4.8E-04, see Figure 3.4 for the distribution of all scores for both data sets).
3.2 Characterization of the signaling interactions
We investigated eleven signaling pathways which had a high overlap with cytokine
receptors, such as the endocrine signaling, cell growth and death and the immune
system pathways (Table 2.1). A total of 663 proteins for which we had phenotypic
data were investigated. Among these proteins, we obtained 1927 and 676 known
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activation and inhibition interactions, respectively. Gene pairs for all sets (activat-
ing protein-protein interactions (Act-PPI), inhibiting protein-protein interactions
(Inh-PPI) and putative interactions with no information regarding activation or
inhibition (Undef-PPI)) were analyzed. We calculated a first set of features by ap-
plying our new concept for feature generation using Linear Discriminant Analyses
(LDAs). For each gene pair, genei and genej, the task of the classifier (LDA) was
to distinguish images of cells with knockdown of genei from images of cells with a
knockdown of genej. The performance of the LDAs served as a similarity criterion.
Features describing the performance of the LDAs ((1) LDA-performance features)
were calculated. Good performance resulted in e.g., high accuracy indicating that
the phenotypes of the two knockdowns were dissimilar hinting at an inhibiting inter-
action. In contrast, weak performance indicated similar phenotypes (hinting at an
activating interaction). As additional features, we employed (2) phenotype-fraction
features derived from counting cells according to the distinct phenotype classes of
interphase, mitosis and apoptosis, and the overall cellular proliferation rates; (3)
maxima features, i.e., the time-point and height of phenotype maxima (maxima
features were obtained from the original Mitocheck study, [98]); and (4) proximity-
features calculated from the distances to well-defined reference genes within a PPI
interaction network. These features are described in Section 2.2.5 and were used
to learn a second set of classifiers (Support Vector Machines, SVMs) to classify the
Act-PPI and Inh-PPI sets. Gene pairs from the Act-PPI and Inh-PPI sets were
trained for the classifiers and their performance was assessed in an independent val-
idation set. The trained machines (trained on the training sets) were used to define
a similarity measure (consistency score). This score was high for a pair of proteins if
their interactions with other proteins were of a similar nature (similar profile, with
both proteins predicted to exhibit either an activating or inhibiting interaction with
the other proteins) and low otherwise (showing a rather different activation/inhibi-
tion profile). Using this score, the performance was improved. The readily trained
classifiers were subsequently used to predict the nature of interactions from the set
of non-defined PPIs. Finally, we applied the consistency scores in a detailed analysis
of cytokine receptor signaling.
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3.2.1 Assembly of known activating, inhibiting and non-
defined interactions
Three (non-overlapping) sets of interactions were defined. Set no. 1 consisted of
well-known interactions that were described as activating. They were taken from a
literature-based data repository (the Kyoto Encyclopedia of Genes and Genomes,
KEGG [66, 67, 155]) and used as a reference, or gold standard for activating PPIs
(Act-PPI). Set no. 2 was taken as inhibiting PPIs (Inh-PPI) and comprised pairs
of genes encoding proteins for which an inhibiting interaction has been reported
(listed in KEGG). Set no. 3 consisted of putative interactions for which there is no
information regarding activation or inhibition (Undef-PPI, undefined PPI). This list
was assembled from computationally inferred high potential interactions and from
entries in a well-curated database (MetaCore, unspecific interaction). To further
restrict to proteins pairs that were very likely to interact, we used these potential
interacting pairs only if their protein domains were predicted to interact (protein-
domain interactions were obtained from a database [161]). With this, we selected
727 non-defined interactions, which served as a basis for new predictions of the
nature of their interactions (activation/inhibition).
3.2.2 Quantifying cell phenotypes
Quantitative profiles of knockdown gene images were generated using an automated
image processing system [55]. Each cell nucleus was segmented using Otsu thresh-
olding and characterized based on morphological descriptors, e.g., Haralick texture,
Zernike moment, granularity features, object-and edge-related features, grey-scale
invariants, and numbers of cells and pixels (Section 2.2.4). These features were used
to distinguish different phenotypes of cells. Each single cell was classified into one
of four morphological classes: interphase, apoptosis, mitosis, or shape (cluster of
cells) using a Support Vector Machine (SVM). The classifier learned to distinguish
the four phenotypic classes from trained morphological classes that were manually
annotated by an expert. Therefore, the fractions of each phenotype based on the
number of cells were computed for each knocked-down genes. Ordinary features,
e.g., cell proliferation and median and standard deviation of the cell intensities, were
also calculated. This feature is termed a “fraction feature”. In addition, we also
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generated other features, called LDA-performance, maxima, and proximity features
(Section 2.2.5), for our pairwise phenotypic features.
3.2.2.1 Cell phenotype classification
We assigned four classes of cellular phenotypes: (1) interphase, (2) mitosis, (3) apop-
tosis (cell death phenotypes), and (4) shape (clustered nuclei). The total number of
manually classified cell objects was 775. The number of cells per class is provided
in Table 3.5. The cell nuclei were characterized automatically from multicellular
images using the segmentation approach, and image features were extracted.
Table 3.5: Number of single cell images separated for training and testing.
Classes Training
set
Test
set
Total
Interphase 252 62 314
Mitosis 172 43 215
Apoptosis 89 22 111
Shape 108 27 135
Total 621 154 775
We split the available samples for each class randomly in training data and testing
data at a ratio 4:1, resulting in a training set size of 621 and a test set size of 154.
We trained an SVM classifier with a Gaussian radial basis function (RBF) kernel on
the training dataset. The samples of the test set were classified into the four classes,
i.e., interphase, mitosis, apoptosis, and shape. We repeated the classification step
applying ten times random sampling on the whole dataset. The performances of
the classification for the training and test sets are shown in Table 3.6 and Table 3.7,
respectively. We yielded an overall accuracy of the training set of 99.62% and of the
test set of 96.62%. Misclassifications mainly occurred between the classes mitosis
and apoptosis, which are difficult to seperate, even through human identification.
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Table 3.6: Confusion matrix for SVM classification of training sets based on Table
3.5. The overall accuracy is 99.62% (618.7/621).
True class
Classifier output
Accuracy
Interphase Mitosis Apoptosis Shape
Interphase 252 0 0 0 100.00%
Mitosis 0 172 0 0 100.00%
Apoptosis 0 2.1 86.9 0 97.64%
Shape 0.2 0 0 107.8 99.81%
Table 3.7: Confusion matrix for SVM classification of test sets based on Table 3.5.
The overall accuracy is 96.62% (148.8/154).
True class
Classifier output
Accuracy
Interphase Mitosis Apoptosis Shape
Interphase 61.1 0 0.9 0 98.55%
Mitosis 0 41.9 1.1 0 97.44%
Apoptosis 0 3 18.9 0.1 85.91%
Shape 0 0 0.1 26.9 99.63%
3.2.2.2 Characterization of the phenotypic similarity and dissimilarity
of cells using LDAs
For each of the 663 genes from the selected cytokine signaling pathways, cell images
of each pair of genes were compared. The approach of using LDAs to describe phe-
notypic similarity is exemplarily described for three sample knockdowns illustrated
in Figure 3.5. Two of the genes, frizzled family receptor (FZD7 ) and dishevelled
2 (DVL2 ), are closely functionally related. DVL2 is activated by FZD7 in the
Wnt signaling cascade [160]. Thus, cellular images following individual knockdown
of these two genes should exhibit phenotypic similarities. In contrast, SFRP1 (se-
creted frizzled-related protein 1) forms an inhibitory complex with the frizzled re-
ceptor and down-regulates Wnt signaling [22]. Hence, this should show a dissimilar
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Figure 3.5: Illustration of the characterization of phenotypic similarity. (a)-(c)
Images of cells in which SFRP1,DVL2 and FZD7, respectively, were knocked down.
(d) First two principal components (PC 1 and PC 2) of the features for cells in
which SFRP1 and DVL2 were knocked down; (e) first two principal components
of the features for cells in which DVL2 and FZD7 were knocked down. The dotted
lines indicate a linear separation.
cellular phenotype after knockdown. Indeed, after knockdown of FZD7 and DVL2,
cells displayed considerably irregular nuclear membranes (Figure 3.5 (b) and Figure
3.5 (c)). In contrast, after knockdown of SFRP1, cells did not show these irregular
patterns (Figure 3.5 (a)) and were therefore better distinguishable from cells after
FZD7 and DVL2 knockdown. We segmented the cells in all images and calculated
a broad range of texture, morphological and shape features for each cell. Feature
vectors were compared for cells in which SFRP1 and DVL2 were knocked down
(dissimilar images) and in which DVL2 and FZD7 were knocked down (similar im-
ages). Figure 3.5 (d) and Figure 3.5 (e) show the results from plotting the first two
principal components (the first two axes associated with the highest variance of the
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Figure 3.6: ROC curves of the classification using subsets of features. We trained
and tested the machines with different subsets of features according to the different
types of phenotypic similarity features: the phenotype fraction features, the LDA-
performance feature, the maxima features, and the proximity features. The figure
shows that the best performance was yielded using all features followed by the set
of proximity features.
data in the feature space). With respect to cells in which FZD7 was knocked down,
cells in which SFRP1 was knocked down were better separable from cells in which
DVL2 was knocked down. Hence, distinguishing knockdown of SFRP1 and DVL2
was easier for the discriminator (LDA), and the LDA therefore yielded better per-
formance values (accuracy: 80.7%) in comparison to DVL2 and FZD7 (accuracy:
70.6%). The LDA was applied to all combinations of pairs in our data and was used
to computed the accuracy, which was one of our similarity features.
3.2 Characterization of the signaling interactions 75
3.2.3 Performance of the identification of activating from
inhibiting PPIs
We trained 100 Support Vector Machines to distinguish the set of activating PPIs
(Act-PPI) from the set of inhibiting PPIs (Inh-PPI). Training and validation were
performed through cross-validation. To obtain different levels of stringency, a vot-
ing scheme was applied: when a classifier predicted an activating interaction, a
positive vote was contributed. Positive votes from all 100 trained SVM-classifiers
were summed to yield the predicted interactions and the number of positive votes
was used to define stringency. We were particularly interested in classifiers with
high stringency. At the highest stringency, remarkably good precision was yielded
when selecting interactions that were predicted unequivocally by all classifiers (pre-
cision: 92%; accuracy: 35%, sensitivity: 13%, specificity: 97%). Using a minimum
90% stringency yielded a high precision (89%) with a considerably high specificity
(87%); the sensitivity was 39%. Figure 3.6 shows the Receiver Operator Characteris-
tics for all features (area under the curve, AUC=0.76) and for the LDA-performance
features alone (AUC=0.57) as well as the phenotype-fraction features (AUC=0.58),
maxima-features (AUC=0.62) and proximity features (AUC=0.66). We obtained
similar results regarding the inhibiting PPIs as true positives and the activating
PPIs as true negatives. Using the consistency score (Section 2.2.9) as a filter, we
improved the precision of the classification performance considerably. This score
expressed the similar or dissimilar nature of two interacting genes with respect to
other genes. Consistency scores were calculated and assigned to all of the interac-
tion pairs in our data. To avoid a bias (overfitting) in computing the consistency
scores, we did not take the known interactions from KEGG into account in com-
puting these scores. At a high stringency of 80%, the precision was improved from
89% to 94% with 1187 selected activation and 392 selected inhibition interactions.
At a middle stringency of 50%, the precision was improved from 84% to 92% with
1177 selected activation and 323 selected inhibition interaction. At a low stringency
of 20%, the precision was improved from 81% to 90% with 1137 selected activation
and 249 selected inhibition interactions.
3.2.4 Validation with other PPI datasets
To validate the approach using an independent dataset, we compared our predic-
tions with the annotation of known interactions from a well-curated literature-based
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database (MetaCoreTM version 6.8, www.genego.com). We applied our method to
all possible gene pairs and calculated their consistency scores. To avoid overfit-
ting, we did not take known interactions from the investigated KEGG pathways
into account. We observed a significant enrichment of gene pairs from the database
for predicting activation (P -value = 3.1E-03) and for predicting inhibition (P -value
= 4.0E-04). We were interested in how our predictions relate to putative interac-
tions with a high confidence from computationally inferred and not experimentally
validated interaction predictions. We used predicted interactions with high confi-
dence scores (scores ≥ 900) from the Search Tool for the Retrieval of Interacting
Genes (STRING [136]). Interestingly, we found that these interactions showed a sig-
nificant enrichment (P -value = 4.6E-03). No significant enrichment for inhibiting
interactions was yielded. This raised two interesting aspects. The computationally
inferred interactions seemed to consist of considerably more activating functions,
and our consistency scores may be suitable for predicting new interactions (which
was beyond the scope of this study).
3.2.5 Predictions for non-defined PPIs
From the set of undefined PPIs (Undef-PPI) we selected gene pairs with a high
number of votes for activation/inhibition and high/low consistency. After discarding
interactions found in the literature database (MetaCore, “specific interaction”), 179
new predictions for activation and new 35 predictions for inhibition were yielded.
Note that we yielded predictions with good confidence more for activation which is
in accordance with the results presented in Section 3.2.3. All 214 predictions can
be found in Appendix A.
We then investigated these predictions in greater detail. Commonly, kinases acti-
vate their substrates, whereas phosphatases deactivate them. Hence, we performed
enrichment tests for these protein groups to validate our predictions and found con-
siderably higher enrichment of kinases and kinase binding proteins in the predictions
of activating interactions (for activation, kinase activity P -value = 1.9E-04, and ki-
nase binding P -value = 2.8E-04; for inhibition, kinase activity P -value = 0.03, and
no significance was found for kinase binding). In addition, we identified signifi-
cant enrichments of phosphatase activities and phosphatase-binding proteins only
in the predictions of inhibiting activations (phosphatase binding P -value = 0.02, py-
rophosphatase activity P -value = 0.01, calcium dependent protein serine/threonine
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phosphatase activity P -value = 0.007). The results of all of the enrichment tests are
presented in Appendix B. We then analyzed the quality of the predicted interactions
of the kinases. We compared the potential kinase activities of our predictions for
activation with all non-defined interactions (Undef-PPIs). Quantitative mass spec-
trometry has been employed in obtaining a massive number of site- and context-
specific in vivo phosphorylation events [15, 23, 81, 84, 85, 93, 138, 140]. Using these
data, computational tools have been developed to predict kinase phosphorylation
events [78, 83, 96, 159] among which we used one of them which contained the
most of our investigated kinases [159]. We found significant enrichment of predicted
phosphorylation events in our predictions of kinases interacting with their potential
substrates (P -value = 0.015, ratio of our predictions to predicted phosphorylation
events: 1.24, other Undef-PPIs: 0.67) and this confirmed our results.
Additionally, we compared our predictions with the literature. Regarding the
top twenty predictions for activation, we found two pairs of genes encoding pep-
tides composing the phospholipase C beta (PLC-β) complex, which are therefore
positively interacting. PLC-γ2 was predicted to positively interact with HCK and
VAV1. This prediction is in accordance with the literature, as HCK was shown to
phosphorylate PLC-γ2 in response to activation of cell surface receptors [80], and
VAV family proteins positively regulated PLC-γ isoforms downstream of ITAM (im-
mune receptor tyrosine- based active motif) receptors [6, 90, 113, 116, 143, 144]. We
found that SRC positively interacts with NFKB and HCK in accordance with an
interesting study addressing an epigenetic switch in which constitutively activated
SRC activates NFKB, linking inflammatory pathways to oncogenic cell transforma-
tion [62]. HCK and SRC are part of the SRC family of kinases (SFKs) and are able
to carry out mutual phosphorylation [101]. As evidence of the predictions regarding
inhibiting interactions, we found, e.g., SHP1 to negatively regulate KIT receptor ty-
rosine kinases [86, 106] and CBLB to negatively regulates CRKL signals in response
to TCR stimulation [167].
3.2.5.1 The best prediction results were yielded for interactions with
cytokine receptors
We were interested in how our predictions were suited for well-defined subgroups of
the signaling network. For this, we investigated three major groups: receptors that
initiate the signaling processes in the cell, central (highly connected) proteins in the
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Figure 3.7: Clustering dendrogram for the cytokine receptors. Three groups of
clusters were identified: a group of interleukin receptors (group 1), a subgroup of
chemokine receptors (group 2) and the rest comprising of interleukin and chemokine
receptors.
pathways, and transcription factors as signal destinations. We selected interactions
containing at least one node of these groups. A considerably better performance
was yielded for the receptors (AUC = 0.92). The group of highly connected pro-
teins showed an average performance (AUC = 0.87), and the transcription factors
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performed more poorly (AUC = 0.51), which may reflect their promiscuous func-
tions. The result for the receptors could be improved by restriction to cytokine
receptors (AUC = 0.97). In the following section, we describe the investigation this
subgroup in more detail.
3.2.5.2 A clustering analysis reveals a new subgroup of chemokine re-
ceptors
We employed the consistency scores of the phenotypes and performed unsupervised
hierarchical clustering of cytokine receptors. Figure 3.7 shows the results of this
analysis. The clustering dendrogram shows three major groups: group 1 mainly
consisted of interleukin receptors, group 2 of a subgroup of chemokine receptors (also
denoted as the CCR-subgroup hereafter), and group 3 included the remainder of the
investigated cytokine receptors. To confirm this clustering, we examined how likely
potential interactions within these groups could be formed, employing the informa-
tion on protein-domain interactions. Interestingly, we found a striking enrichment of
domain interactions in the group of chemokine receptors (P -value = 1.8E-09). This
was the only group for which any protein was predicted to mutually interact with any
other protein in the group (ten mutual interactions). Group 3 showed a much lower,
but still significant, enrichment of these interactions (P -value = 0.01, only 42 out of
211 possible interactions). In contrast, the group of interleukins (group 1) showed
no enrichment of these protein-domain interactions. Subsequently, we focused our
investigations on the detected novel subgroup of five chemokine receptors, i.e., the
subgroup of CCR1, CCR3, CCR4, CXCR4 and CXCR6. Clustering all chemokine
receptors (using only the consistency scores of the chemokine receptors) confirmed
the clustering of the phenotypes of the identified subgroup (Figure 3.8). We further
validated that these five CCR genes form a subgroup through a co-expression anal-
ysis. We used a large set of 5896 gene expression profiles from microarrays (from 76
different studies from the CAMDA 2007 competition). We compared the correlation
of the expression levels of pairs within the subgroup of CCRs with the correlation of
pairs within the group of other CCRs. We found a significantly higher correlation
in our subgroup of CCRs (P -value = 2.3E-03) demonstrating the close relationship
of the CCRs in this subgroup compared to the other CCRs.
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Figure 3.8: Clustering dendrogram for the group of chemokine receptors. The
subgroup of chemokine receptors consisting of CCR1, CCR3, CCR4, CXCR4 and
CXCR6 clustered together.
3.2.5.3 Investigation of gene groups functionally related to chemokine
receptor signaling supports the identification of the new sub-
group of CCRs
To elucidate the functional interplay between chemokine receptors and their direct
upstream and downstream interactors, we selected the following gene groups: the
chemokine receptors themselves; their potentially activating ligands; Jak1, Jak2,
Jak3 and Tyk2 as their direct downstream signaling targets activating the Jak/-
Stat signaling cascades [127]; G-proteins mediating the PI3kinase/Akt signaling of
chemokines (chemokines are G-protein coupled receptors, [157]); and the members
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Figure 3.9: Functional interplay of chemokine receptors. This figure shows the func-
tional interplay of chemokine receptors and their direct upstream and downstream
interactions. The thickness of the arrows is related to the consistency score between
the groups.
of the SOCS family, which inhibit cytokine signaling [162]. To investigate how our
subgroup of CCRs is distinguished from the other CCRs, we partitioned the inves-
tigated CCRs into two groups: our subgroup and the rest of CCRs. To determine
the mutual phenotypic similarity between the investigated groups, we averaged the
consistency scores of gene pairs within the groups and between the groups. Figure
3.9 shows the results of this analysis. Thick arrows indicate high consistency, which
thick inhibition arcs indicate very inconsistent phenotypes. We found a high con-
sistency within each group (e.g., CCR-subgroup - CCR-subgroup: 0.94, CCR-rest -
CCR-rest: 0.59; in comparison, the average consistency of all gene pairs investigated
was 0.39). The pairs between all of these groups (except the group of SOCS genes)
also showed a higher similarity of phenotypes when compared to the average of all
pairs of investigated genes (Table 3.8). As expected, the protein pairs between the
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SOCS family member and their target groups showed very low consistency scores,
reflecting their inhibitory nature. Interestingly, the pairs including genes from the
CCR subgroup exhibited significantly higher consistency scores when compared to
the respective pairs containing genes from the group of the rest of CCRs (CCR-
subgroup - Ligands vs. CCR-rest - Ligands: P -value = 3.1E-04; CCR-subgroup
-Jaks vs. CCR-rest - Jaks: P -value = 1.08E-12; CCR-subgroup - G-protein vs.
CCR-rest - G-protein: P -value = 3.41E-07), supporting our hypothesis that they
are particularly strongly related.
3.2.5.4 Knockdown of CCR subgroup genes results in higher cell prolif-
eration
We found the CCR subgroup to be distinctively different from the rest of CCRs.
We then wanted to obtain insight into how they are different. The maxima features
have been well proven to identify and characterize genes related to cell cycle events,
such as mitotic delays [98]. We used the maxima features in comparing the genes of
the CCR-subgroup with the rest of investigated CCR genes. Interestingly, cells in
which genes of the CCR-subgroup were knocked down showed significantly higher
Table 3.8: Mean of consistency score between the CCR-subgroup and other groups.
Mean of con-
sistency score
CCR-subgroup Ligands 0.49
CCR-subgroup Jaks/Tyk 0.86
CCR-subgroup SOCSs 0.21
CCR-subgroup G-Proteins 0.59
The rest of CCRs Ligands 0.47
The rest of CCRs Jaks/Tyk 0.59
The rest of CCRs SOCSs 0.38
The rest of CCRs G-Proteins 0.48
CCR-subgroup CCR-subgroup 0.95
The rest of CCRs The rest of CCRs 0.52
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proliferation rates compared to when the rest of CCRs were knocked down (P -
value = 1.26E-03). Additionally, regarding all investigated CCRs showed that this
yielded higher proliferation in comparison to all other investigated genes. Still, for
our subgroup, this effect was considerably stronger apparent (significance of higher
proliferation of the CCR-subgroup in comparison to all other genes: P -value =
3.73E-06; in contrast, significance of the rest of CCRs versus all investigated genes:
P -value = 0.523). We validated these results using an independent public repository
produced from a large scale knockdown screen of 72 cell lines from breast, ovarian
and pancreas tumors [73]. This screen contained the essentiality information for
approximately 16,000 genes, including nearly all (98.6%) of our investigated genes.
We argued to have a validation of proliferative influence of a knocked-down gene, if
we obtained a depletion of essentiality hits in this screen, when comparing our gene
list with the rest of our investigated genes. We again performed two comparisons; we
compared 1) our CCR-subgroup with the rest of CCRs, and 2) our CCR-subgroup
with the rest of all investigated genes. Both comparisons confirmed the results,
comparison CCR-subgroup versus the rest of CCRs: P -value = 4.0E-05, genes from
our subgroup were experimentally proven to be 10 times essential and 350 times non-
essential in the 72 cell lines (ratio: 0.029), whereas genes from the rest of CCRs were
proven to be 39 times essential and 321 times non-essential (ratio: 0.12); comparison
CCR-subgroup versus the rest of all investigated genes: P -value = 0.0055, the rest
of all investigated genes showed 2894 times to be essential and 44,194 times to be
non-essential (ratio: 0.065) in the data of Koh and coworkers [73]. These results
confirmed our finding that genes from our CCR subgroup may induce proliferation
after knockdown.
Chapter 4
Summary and discussion
4.1 Summary and discussion
In this thesis, I firstly described a new alternative approach to detect host factors
(human proteins) involved in HCV infection relying on a fluorescence microscopy
imaging of RNAi knockdown screen. The clustering score based on the K -function
and was defined to identify the clustering of infected cells. Through the investigation
of the alteration of clusters of infected cells after perturbating a gene, we identified a
set of potential genes (hits) from our analysis. We compared our targeted host fac-
tors with hits from experimental primary and secondary screens, yielding promising
gene products that might suit for drug targets. Secondly, I described a new devel-
opment that based on a machine learning system to characterize the activities of
protein-protein interactions from RNAi of HeLa cells. Both published phenotypic
descriptors and our own developments were calculated and used for classifications
of the activities of protein-protein interaction. A consistency score was established
to describe the nature of two interacting proteins and supported to identify the
confidence of the predictions. We yielded lists of activation and inhibition predic-
tions. The lists of characterized interactions contributed to our understanding of
signal transduction. Additionally, a subset of chemokine receptors was revealed and
might yield new insights in chemokine signaling which plays an important role in
inflammation and infectious diseases.
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4.1.1 Clustering of cells infected with Hepatitis C Virus
We applied a clustering analysis method and statistical analyses of intensity readouts
to detect host factors involved in HCV infection. Instead of observing the knockdown
of viral components, we focused on specific proteins in the host cell. Targeting host
factors that were relevant to viral replication led to distinctively lower clustering of
the infected cells. Specifically, all three positive controls showed significantly low
clustering scores. Additionally, we obtained hits showing significantly low viral GFP
intensities in the primary screen and hits from a secondary screen using a luciferase-
based readout. Computation of the intersection of hits from all three approaches
yielded five genes to be considered as attractive targets against HCV infection.
Infected cells in the experimental screens showed non-random clustering distribu-
tions which has been caused by the spreading of the virus infection. We established
a clustering score that was based on the K -function, a distance-based method. The
K -function enables to quantify clustering, random, or dispersion distribution at
many distances. It allows observing a combination of distributions, e.g., clustering
at small scales and regularity at large scales. The combination effects can be ob-
served as a characteristic pattern in a plot of the K -function compared with the null
hypothesis determined from a random distribution. Using the K -function, we did
not have to pre-define the number of clusters or neighbouring cells before the cal-
culation likes the other methods, as e.g., methods basing on a k -nearest neighbour
approach. However, one parameter that we needed to determine for calculating the
clustering score was the maximum range of our investigated circular radius from a
cell. This parameter depends on the spreading characters of data. We varied the
maximum range of the radius and selected the optimal one that showed the optimal
correlation coefficients between our clustering score and the intensity values from
the experimental screens.
We also applied an alternative clustering method, the quadrat analysis, to mea-
sure the infection phenomena of the cell distribution. For this comparison we chose
the quadrat analysis method, as similar to the K -function. The quadrat analysis has
also the advantage to analyze a distribution statistically in comparison to any distri-
butions. However, the results from our analysis after applying the quadrat analysis
showed that the correlation between the clustering score computed from the quadrat
analysis and the intensity scores from primary and secondary experimental screens
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were much lower than using the K -function. An explanation for this is that the
quadrat analysis needs to divide the studied area into a set of grid squares, followed
by computing the variability of numbers of points in the grids by a coefficient index
that is the variance-mean ratio. If this ratio is nearly to one, the distribution is a
random distribution. A ratio greater than one indicates a cluster distribution while
a ratio lower than one indicates a uniform distribution. It turned out that the size
of the grids is crucial for this. We tried a variety of quadrat sizes. If grid size is
too small, there are a lot of empty grid and the statistical test, variance-mean ratio,
could not work successfully. If the grid size is too large, it is difficult to detect a
cluster distribution of cells. With these limitations, the grid analysis had a bias in
detecting the distribution of the cells on our screens.
The homogeneous K -function is commonly used for identifying the distribution
of point patterns. The function is computed based on a constantly estimated density
for the whole screen. However, for more realistic distributions, the inhomogeneous
K -function has been used for our analysis. The inhomogeneous K -function has
been used in a wide variety of scientific applications, ranging from the analysis
of the clustering behavior of infected habitants in a country [41] to cell biological
concerns such as studying the clustering of integrins when cells sense the extra
cellular matrix [102]. The inhomogeneous K -function has the same principle as the
homogeneous K -function but additionally considers the variation of the intensity
over the studied areas. This investigation corresponds to our problem that the
infections of cells varied in the different area of the screens which are naturally
affected by the spreading of viral particles from a cell to its neighbours. Hence, the
inhomogeneous K -function was more suitable for our problem. This explanation
was supported by our experimental results which showed the correlation coefficients
of the clustering scores for the inhomogeneous K -function and the intensities of
the experimental screens were relatively higher than those correlations using the
homogeneous K -function. At the maximum radius range of 35% of the images,
the correlation coefficients of the clustering scores from the inhomogeneous and
homogeneous K -functions with the primary screens were 0.55 and 0.36, respectively.
These results supported that the inhomogeneous K -function is more suitable for our
application.
We applied established statistical normalization techniques and yielded 30 candi-
date targets from our clustering methods. When we compared our candidate targets
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with the hits from the primary and secondary screens, we yielded five overlapping
proteins. With this, we recovered known host factors and new candidate genes. Be-
sides two well-known host factors that are relevant for HCV replication (CD81 and
PI4KA) and one host factor that has been described as phosphorylating an HCV
protein, we found two new interesting candidates (FLT-4 and SLAMF-6). FLT-4 is a
membrane protein and therefore easy targetable by immune cells. It has interesting
characteristics. It was observed that it was suited for a retrovirus when genomically
incorporated [61]. It will be a challenge to verify FLT-4 experimentally. Then, an
important step will be the drug design. To validate the results, gene knockdown
experiments may be applied to other liver cell lines that are permissive for HCV
replications to observe the infection efficiency of the same knockdown genes.
We used the K -function for observing the clustering behavior of individual in-
fected cells in a cellular in vitro assay. With this clustering analysis method, we
were able to track the infection of populations in a systematic way and, thus, to
detect host factors for viral replication. In addition to apply the K -function to de-
tect relevant host factors as shown in this study, it may be applied to systematically
investigate the infection behavior of different virus families. Snijder and co-workers
observed principal differences in virus entities to populate cell samples [126]. The
K -function may be used in a follow up analysis of the present study through a quan-
titative clustering analysis supporting a novel taxonomy for virus strains based on
their population characteristics in the host. For example, it is known that Dengue
virus infects the edges of islets in cell colonies and therefore does not exhibit a clus-
tering tendency like HCV does [126]. In an initial trial, we observed distinct, higher
clustering scores for cells infected with HCV in comparison with cells infected by
the Dengue virus.
In summary, the application of a clustering analysis method for estimating viru-
lence in cellular assays is general, and this method can be used in other screens to
observe infectious propagation in cellular populations. It may also be used to per-
form a quantitative and systematic analysis of the specific spreading and populating
behavior of distinct virus families, which may have an impact on the discovery of
their specific use of host cells.
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4.1.2 Characterization of signaling interactions
We developed a machine learning-based approach for characterizing the activi-
ties of protein-protein interactions. The gold standard of the class labels in the
classifications was collected from the KEGG database, which is a comprehensive
database providing the interacting information for each interaction with evidences
from the literature. A systematic classification was established for distinguishing
activation and inhibition interaction using pairwise phenotypic descriptors of gene
perturbation. Only a few sets of basic phenotypic similarity features did not yield
a good protein-protein activity characterization. In contrast, integrating these
features with other developed features yielded a far more comprehensive model.
We mainly got our features from four groups comprising the phenotype-fraction
features, LDA-performance features, maxima features, and proximity features.
Feature analyses
The performance of the classifiers using each single set of the features were mea-
sured. In comparison to the other feature sets, the proximity features yielded
the best performance (AUC of 0.66). This makes sense because the proximity
features employed the distances computed from both the LDA-performance and
the Maxima features. This set of features may contain more variety of informa-
tion for the classification. Another possible reason might be that the proximity
features increased the dimension of the distance features for an interaction. In-
stead of computing a distance of a protein pair directly, the distance between
these two proteins were computed from the distance from each protein to other
distinct proteins. The LDA-performance is an important feature even it showed a
very low performance (AUC of 0.57) when solely used. When we discarded this
LDA-performance feature from our analysis (also discarded from the Proximity
features), the overall performance was decreased from the AUC of 0.76 to the AUC
of 0.72. The result was similar to the Phenotype-fraction features that the overall
performance was decreased to the AUC of 0.73. Therefore, we combined all feature
sets for the machine learning system. All feature sets were used for training and
testing our machine learning approach using SVMs with a voting scheme technique.
An advantage of the technique is the ability to change the stringency parameter
to increase precision and to avoid losing potential candidates. The comprehensive
model from the machines was used to further predict other interacting protein pairs.
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Voting scores and consistency scores
Apart from the voting score for defining the confidence of each predicted inter-
action, we additionally computed the consistency score for each interacting pair.
The consistency score was calculated to identify how likely an interaction processes
an activating or inhibiting signal. The consistency score was rigorously computed
for an interacting pair, avoiding any biases which could have occurred from the
known class labels and trained machines. We used this consistency score to filter
out interactions with ambiguous predictions and this improved the precision 7.2%
on average. However, a limitation of computing this consistency score is the number
of all proteins in the observed pathway. Due to the fact that the score is computed
from the percentages of all proteins showing consistent or inconsistent activities with
the two proteins for which the prediction is made, higher numbers of proteins yield
more reliability. If the number of all proteins in the analysed system is too less, the
consistency score might not be appropriate.
Additionally, the performance of the machine learning system to classify the ac-
tivities of protein-protein interactions to be an activating or inhibiting signal is also
important for computing the consistency score. The higher the performance of the
classification system to classify the activities is, the more precise these predicted
activities become to investigate the consistent (or inconsistent) interaction of a pro-
tein pair to other proteins. To obtain a good performance for the classification, the
number of samples for training the system is one of the important factors. Gener-
ally, many pathways do not provide enough information of the interacting activities.
We focused on signal transduction pathways which provided us with high numbers
of activating/inhibiting interactions for the machine learning system. The results
showed that our systematic classification could be well performed to classify between
activating and inhibiting interactions and used in the calculation of the consistency
score.
The two scores (from the voting scheme and the consistency score) provided
additional information for more precise identification of potential activation and
inhibition interactions. Lists of the predicted 179 activations and 35 inhibitions
with voting scores and consistency scores were produced. We validated the rele-
vance of our consistency scores using other independent databases through GSEA
enrichment tests. The results yielded a significant enrichment of well-defined,
known interactions. In the application of the cytokine receptor analysis, we found
90 Summary and discussion
a subset of chemokine receptors, consisting of CCR1, CCR3, CCR4, CXCR4 and
CXCR6, that showed a significantly high correlation in our co-expression analysis
and their relevance is further discussed in the next section.
Application for Cytokine signaling
Cytokine receptors act as dimers or even higher order oligomers [76, 94]. We went
into the literature to find evidence of common action of the gene products of the
detected subgroup. Seidl et al. [122] investigated the gene expression profiles of
chemokine receptors using real-time PCR in melanocytes, melanoma cell lines and
primary and metastatic melanoma. They found the pair of CXCR4 and CCR1
to be consistently expressed in all of these different melanoma cells, and in the
present study, CXCR6 was found to be expressed de novo in primary melanomas
and melanoma metastases. Among chemokine receptors, CXCR4 and CXCR6 have
been reported in several studies to play a predominant role in the development and
progression of solid tumors. CXCR4 and CXCR6 interact with tumor cells by acti-
vating the AKT/mTor signaling pathway [32]. Furthermore, CXCR4 is also known
to activate cancer progression through the JAK/STAT pathway [148], and CXCR4
is associated with a poor prognosis in cervical cancer patients [72]. CXCR4 and
CXCR6 are highly expressed in gynecological tumors and in inflammation associ-
ated tumors, respectively, and both play important roles in the growth, prolifer-
ation, invasion, and metastasis of epithelial ovarian carcinomas [50]. CXCR6 has
been found to be highly involved in the metastasis and progression of several types
of cancer [32]. The development and aggressiveness of prostate cancer involve the
CXCL16/CXCR6 axis [51]. CXCR6 and CXCR4 are expressed in similar propor-
tions in malignant prostate tumors and benign prostate hyperplasia tissue, and both
are highly expressed in malignant tissue [60]. Our results demonstrate the common
phenotypes of CXCR4 and CXCR6. CCR1, CCR3, CCR4 and CXCR4 were re-
ported to function in human platelets activated in patients infected with human
immunodeficiency virus (HIV) and may be commonly involved in inflammatory or
allergic responses [24]. Interestingly, in HeLa cells, it was shown that CXCR4 was
cross-desensitized by a ligand for CCR4. In chemotaxis, CKLF1 is an activator of
CCR4, and SDF1 is an activator of CXCR4. CKLF1 could inhibit the effect of
SDF1, which was mediated by CCR4, as SDF1 could be rescued, acting as an acti-
vator of chemotaxis after blocking CCR4 [168]. Together with our finding of similar
knockdown phenotypes of these receptors, we suggest that both receptors may signal
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through very similar downstream cascades. This may be potentiated for one receptor
when the other receptor is absent, leading to the same phenotypic shape, regardless
of which of the receptors is expressed. Taken together, these results suggest that the
member of our subgroup of chemokine receptors exhibit similar functions, and they
may even follow similar signaling routes, leading to similar phenotypes following
being knockdown.
In conclusion, we developed a machine learning-based approach for predicting
interactions involved in the activation or inhibition in the signal transductions. The
machines integrated all our developed and published pairwise phenotypic descrip-
tors. We established a consistency score which can be applied to identify the nature
of two interacting proteins. Our developed approach is general and can be broadly
applied to a larger signaling network. This approach can be exploited to avoid
experimental limits of time and cost and might also be applied to the analyses of
human disease pathways and networks.
4.2 Outlook
Investigation phenotypes from double knockdowns of infected cells associated with
known host factors compared to others may reveal insight with respect to identify-
ing missing cooperative host factors. With this, machine learning can be applied to
recognize infected cell characteristics and perform combined host factor predictions.
Integrating the cell characterization information and the host-pathogen interaction
network may reveal a set of host cofactor proteins that the virus need for the repli-
cation. RNAi screens using time-lapse imaging of cells infected with the virus may
explore different temporal patterns of infected cells. Tracking the clustering of cells
in different time steps may reveal the optimal functional time point for which the
virus requires the host factors.
Signaling networks are highly complex. Thus, understanding the system requires
a global view of cellular networks. In characterizing the activities of protein-protein
interactions, it will be a challenge to integrate all available and reliable protein-
protein interaction information from all databases. It will also be a challenge to
apply our method to all possible signaling pathways. This application will aid in
achieving improved insight into the whole system of a human cell. Validating the
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predicted activation and inhibition interactions with protein structures will also be
useful to obtain additional evidence of these interactions. In terms of the pairwise
phenotypic descriptors, similarities of protein sequences are interesting additional
features to explore. Gene ontology may provide hints to identify proteins that are
related in terms of function. Additionally, Tan et al. [138] reconstructed a conserved
phosphorylation (kinase-substrate) network. These phosphorylation events could be
included in our model. Furthermore, we can apply our method in a smaller kinome-
wide RNAi screen to observe which kinases are activating and inactivating for a
given specific treatment or condition.
Appendix A
List of predicted activation and
inhibition interactions
Table A.1: List of predicted activation interactions with high vote scores (900-
1000) ranked with consistency scores (higher than average); interactions are taken
from the STRING database with predicted Domain-interaction database and specific
MetaCore interactions are discarded.
Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
6714 4790 SRC NFKB1 1000 0.9950
6714 8440 SRC NCK2 998 0.9903
6714 10746 SRC MAP3K2 999 0.9892
23236 5336 PLCB1 PLCG2 989 0.9892
1230 10663 CCR1 CXCR6 1000 0.9834
658 7046 BMPR1B TGFBR1 975 0.9788
5332 23236 PLCB4 PLCB1 1000 0.9664
1499 7046 CTNNB1 TGFBR1 1000 0.9627
4171 4172 MCM2 MCM3 913 0.9604
6714 3055 SRC HCK 1000 0.9574
93 658 ACVR2B BMPR1B 902 0.9534
5970 4790 RELA NFKB1 958 0.9513
3717 4790 JAK2 NFKB1 995 0.9468
3055 5336 HCK PLCG2 998 0.9444
6714 5604 SRC MAP2K1 995 0.9444
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
1232 10663 CCR3 CXCR6 1000 0.9436
5336 7409 PLCG2 VAV1 949 0.9436
658 657 BMPR1B BMPR1A 965 0.9384
5331 23236 PLCB3 PLCB1 992 0.9375
6714 5582 SRC PRKCG 987 0.9266
5332 5336 PLCB4 PLCG2 985 0.9233
93 92 ACVR2B ACVR2A 1000 0.9199
6714 5880 SRC RAC2 951 0.9151
2066 2065 ERBB4 ERBB3 937 0.9139
6360 10563 CCL16 CXCL13 967 0.9126
2921 10563 CXCL3 CXCL13 999 0.9101
8797 4790 TNFRSF10A NFKB1 999 0.9047
6352 10563 CCL5 CXCL13 974 0.8931
2921 6366 CXCL3 CCL21 989 0.8900
6366 2919 CCL21 CXCL1 994 0.8836
92 657 ACVR2A BMPR1A 916 0.8819
6772 4790 STAT1 NFKB1 998 0.8768
939 7186 CD27 TRAF2 1000 0.8714
8440 8976 NCK2 WASL 959 0.8714
6387 10563 CXCL12 CXCL13 966 0.8677
6363 10563 CCL19 CXCL13 914 0.8600
5331 5336 PLCB3 PLCG2 998 0.8520
5608 57551 MAP2K6 TAOK1 996 0.8456
4690 6714 NCK1 SRC 997 0.8412
958 7186 CD40 TRAF2 999 0.8345
6360 6366 CCL16 CCL21 913 0.8345
408 409 ARRB1 ARRB2 994 0.8298
3055 9564 HCK BCAR1 997 0.8251
6387 6366 CXCL12 CCL21 945 0.8251
6654 6714 SOS1 SRC 1000 0.8226
4792 7186 NFKBIA TRAF2 995 0.8177
5608 25 MAP2K6 ABL1 974 0.8100
2268 3055 FGR HCK 966 0.8074
5155 5154 PDGFB PDGFA 947 0.8074
5584 4790 PRKCI NFKB1 974 0.8048
6654 8440 SOS1 NCK2 1000 0.7994
1436 9564 CSF1R BCAR1 996 0.7966
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
4772 4775 NFATC1 NFATC3 991 0.7938
1499 5590 CTNNB1 PRKCZ 950 0.7938
2268 6714 FGR SRC 1000 0.7853
6714 5590 SRC PRKCZ 994 0.7853
4790 5590 NFKB1 PRKCZ 976 0.7824
998 5608 CDC42 MAP2K6 979 0.7734
6352 5473 CCL5 PPBP 993 0.7673
1237 10663 CCR8 CXCR6 948 0.7641
6367 6376 CCL22 CX3CL1 947 0.7610
3554 4790 IL1R1 NFKB1 923 0.7610
6366 6363 CCL21 CCL19 993 0.7578
6885 659 MAP3K7 BMPR2 995 0.7545
5196 5473 PF4 PPBP 943 0.7545
6714 1398 SRC CRK 985 0.7512
1237 1232 CCR8 CCR3 967 0.7512
2268 5336 FGR PLCG2 947 0.7446
3716 5608 JAK1 MAP2K6 998 0.7412
8312 7046 AXIN1 TGFBR1 954 0.7378
2185 5582 PTK2B PRKCG 939 0.7378
6352 6367 CCL5 CCL22 996 0.7343
3572 3055 IL6ST HCK 953 0.7343
6654 3055 SOS1 HCK 982 0.7272
1237 1230 CCR8 CCR1 968 0.7237
2921 2919 CXCL3 CXCL1 922 0.7237
6654 5296 SOS1 PIK3R2 1000 0.7200
6352 6360 CCL5 CCL16 999 0.7164
1432 6714 MAPK14 SRC 1000 0.7089
998 5880 CDC42 RAC2 989 0.7051
5321 5604 PLA2G4A MAP2K1 1000 0.7013
4214 4790 MAP3K1 NFKB1 991 0.7013
1432 2057 MAPK14 EPOR 948 0.7013
92 4092 ACVR2A SMAD7 998 0.6975
3572 7409 IL6ST VAV1 960 0.6975
2921 5473 CXCL3 PPBP 942 0.6975
6774 51701 STAT3 NLK 954 0.6936
994 995 CDC25B CDC25C 919 0.6856
8795 4790 TNFRSF10B NFKB1 993 0.6816
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
1432 1499 MAPK14 CTNNB1 999 0.6692
9180 3572 OSMR IL6ST 970 0.6608
6372 5473 CXCL6 PPBP 939 0.6565
4214 5970 MAP3K1 RELA 966 0.6522
5584 998 PRKCI CDC42 951 0.6434
324 699 APC BUB1 974 0.6390
2268 9564 FGR BCAR1 970 0.6390
3627 5196 CXCL10 PF4 964 0.6390
3716 3055 JAK1 HCK 994 0.6345
659 4091 BMPR2 SMAD6 927 0.6345
2064 7046 ERBB2 TGFBR1 984 0.6253
3716 4296 JAK1 MAP3K11 962 0.6253
6654 5880 SOS1 RAC2 994 0.6207
1271 3572 CNTFR IL6ST 993 0.6207
5604 6776 MAP2K1 STAT5A 990 0.6207
3815 7409 KIT VAV1 939 0.6113
1432 5604 MAPK14 MAP2K1 925 0.6113
3627 6366 CXCL10 CCL21 923 0.6113
6774 4790 STAT3 NFKB1 992 0.6066
1432 4215 MAPK14 MAP3K3 991 0.6018
6352 6363 CCL5 CCL19 963 0.6018
5580 5604 PRKCD MAP2K1 960 0.6018
25 9564 ABL1 BCAR1 951 0.6018
3717 4792 JAK2 NFKBIA 995 0.5969
5576 6195 PRKAR2A RPS6KA1 979 0.5969
3716 5604 JAK1 MAP2K1 980 0.5920
5473 2919 PPBP CXCL1 925 0.5920
5295 4790 PIK3R1 NFKB1 990 0.5821
6360 6363 CCL16 CCL19 983 0.5821
6352 6372 CCL5 CXCL6 981 0.5821
5295 23236 PIK3R1 PLCB1 956 0.5821
5473 6363 PPBP CCL19 953 0.5821
6363 2919 CCL19 CXCL1 947 0.5821
5604 7531 MAP2K1 YWHAE 925 0.5771
4214 6885 MAP3K1 MAP3K7 1000 0.5720
6654 2549 SOS1 GAB1 968 0.5720
6352 6361 CCL5 CCL17 907 0.5720
Continued on next page...
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
1432 3055 MAPK14 HCK 949 0.5669
9133 4342 CCNB2 MOS 932 0.5669
4690 5747 NCK1 PTK2 998 0.5618
5335 5336 PLCG1 PLCG2 993 0.5618
8569 5321 MKNK1 PLA2G4A 945 0.5566
1432 3716 MAPK14 JAK1 932 0.5566
2064 5604 ERBB2 MAP2K1 977 0.5513
3627 10563 CXCL10 CXCL13 963 0.5513
4214 4296 MAP3K1 MAP3K11 934 0.5513
5576 5566 PRKAR2A PRKACA 997 0.5407
10681 5308 GNB5 PITX2 990 0.5407
4914 25 NTRK1 ABL1 981 0.5353
5770 1436 PTPN1 CSF1R 975 0.5353
6654 4690 SOS1 NCK1 967 0.5353
5604 6774 MAP2K1 STAT3 984 0.5299
6370 2919 CCL25 CXCL1 939 0.5299
998 4690 CDC42 NCK1 994 0.5244
5473 6370 PPBP CCL25 951 0.5244
5576 5577 PRKAR2A PRKAR2B 987 0.5189
4091 657 SMAD6 BMPR1A 910 0.5134
658 7048 BMPR1B TGFBR2 964 0.5078
6372 6366 CXCL6 CCL21 920 0.5078
2057 6772 EPOR STAT1 908 0.5078
1398 5747 CRK PTK2 903 0.5078
658 4089 BMPR1B SMAD4 999 0.5022
8408 9706 ULK1 ULK2 984 0.5022
1432 3718 MAPK14 JAK3 973 0.5022
2921 6363 CXCL3 CCL19 970 0.5022
4215 7531 MAP3K3 YWHAE 962 0.4908
3551 8797 IKBKB TNFRSF10A 943 0.4908
5335 7409 PLCG1 VAV1 910 0.4908
6370 6363 CCL25 CCL19 961 0.4850
207 2065 AKT1 ERBB3 999 0.4792
5335 5332 PLCG1 PLCB4 992 0.4792
2064 5747 ERBB2 PTK2 959 0.4733
5159 5747 PDGFRB PTK2 985 0.4675
4792 5590 NFKBIA PRKCZ 910 0.4675
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
5156 5159 PDGFRA PDGFRB 923 0.4615
994 993 CDC25B CDC25A 917 0.4615
1031 990 CDKN2C CDC6 988 0.4555
5568 5577 PRKACG PRKAR2B 971 0.4555
6361 6367 CCL17 CCL22 951 0.4555
5770 9564 PTPN1 BCAR1 979 0.4495
5921 5894 RASA1 RAF1 949 0.4435
5500 5499 PPP1CB PPP1CA 933 0.4435
8312 207 AXIN1 AKT1 1000 0.4374
57154 657 SMURF1 BMPR1A 974 0.4374
5563 10891 PRKAA2 PPARGC1A 942 0.4374
2064 3717 ERBB2 JAK2 999 0.4312
5604 5295 MAP2K1 PIK3R1 994 0.4251
815 816 CAMK2A CAMK2B 990 0.4251
7048 1499 TGFBR2 CTNNB1 993 0.4063
5575 5568 PRKAR1B PRKACG 983 0.3936
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Table A.2: List of predicted inhibition interactions with low vote scores (0-100)
ranked with consistency scores (lower than average); interactions are taken from the
STRING database with predicted Domain-interaction database and specific Meta-
Core interactions are discarded.
Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
868 1399 CBLB CRKL 0 -0.3006
891 1022 CCNB1 CDK7 26 -0.2517
868 1398 CBLB CRK 66 -0.1796
5777 3815 PTPN6 KIT 80 -0.1353
701 57551 BUB1B TAOK1 20 -0.1130
701 324 BUB1B APC 19 -0.0980
867 5296 CBL PIK3R2 1 -0.0151
207 10971 AKT1 YWHAQ 33 -0.0151
701 7157 BUB1B TP53 88 0.0227
1432 6300 MAPK14 MAPK12 1 0.0755
5970 5595 RELA MAPK3 60 0.0830
5598 5595 MAPK7 MAPK3 48 0.1353
867 2268 CBL FGR 5 0.1796
1432 5330 MAPK14 PLCB2 22 0.1869
3265 3667 HRAS IRS1 27 0.2231
701 890 BUB1B CCNA2 5 0.2374
3643 5295 INSR PIK3R1 5 0.2374
701 51343 BUB1B FZR1 23 0.2374
7132 4217 TNFRSF1A MAP3K5 21 0.2446
112 114 ADCY6 ADCY8 58 0.2658
112 108 ADCY6 ADCY2 88 0.2658
5601 4804 MAPK9 NGFR 88 0.2728
1432 9021 MAPK14 SOCS3 7 0.2937
5516 5515 PPP2CB PPP2CA 93 0.2937
5335 5330 PLCG1 PLCB2 1 0.3006
3575 6777 IL7R STAT5B 22 0.3006
108 196883 ADCY2 ADCY4 45 0.3006
867 4690 CBL NCK1 5 0.3074
4792 207 NFKBIA AKT1 98 0.3143
998 56924 CDC42 PAK6 23 0.3479
3554 929 IL1R1 CD14 6 0.3546
5530 5532 PPP3CA PPP3CB 50 0.3742
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Gene
ID1
Gene
ID2
Gene
Name 1
Gene
Name 2
Votes Consistency
score
1871 894 E2F3 CCND2 97 0.3742
115 112 ADCY9 ADCY6 36 0.3807
1019 8900 CDK4 CCNA1 6 0.3872
Appendix B
Gene ontology enrichments
Table B.1: Significant Gene Ontology enrichments of genes in the predicted activa-
tion interactions.
GO.ID Term Annotated Significant P-value
GO:0004713 protein tyrosine kinase activity 152 54 9.50E-07
GO:0042379 chemokine receptor binding 29 17 5.80E-06
GO:0008009 chemokine activity 27 16 9.30E-06
GO:0004674 protein serine/threonine kinase activity 157 52 2.20E-05
GO:0004672 protein kinase activity 171 55 3.20E-05
GO:0004715 non-membrane spanning protein tyrosine
kinase activity
14 10 5.40E-05
GO:0030554 adenyl nucleotide binding 188 58 7.50E-05
GO:0032559 adenyl ribonucleotide binding 188 58 7.50E-05
GO:0005057 receptor signaling protein activity 46 21 7.60E-05
GO:0016773 phosphotransferase activity, alcohol group
as acceptor
185 57 9.50E-05
GO:0019901 protein kinase binding 80 30 0.00018
GO:0016301 kinase activity 193 58 0.00019
GO:0019899 enzyme binding 147 47 0.00021
GO:0016772 transferase activity, transferring
phosphorus-containing groups
194 58 0.00022
GO:0017076 purine nucleotide binding 203 60 0.00024
GO:0032553 ribonucleotide binding 203 60 0.00024
GO:0032555 purine ribonucleotide binding 203 60 0.00024
GO:0000166 nucleotide binding 208 61 0.00026
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GO ID Term Annotated Significant P-value
GO:0005524 ATP binding 182 55 0.00026
GO:0019900 kinase binding 89 32 0.00028
GO:0070411 I-SMAD binding 9 7 0.00037
GO:0016362 activin receptor activity, type II 5 5 0.00037
GO:0048020 CCR chemokine receptor binding 7 6 0.00044
GO:0004871 signal transducer activity 210 60 0.00074
GO:0060089 molecular transducer activity 210 60 0.00074
GO:0035639 purine ribonucleoside triphosphate binding 197 57 0.00076
GO:0019199 transmembrane receptor protein kinase ac-
tivity
33 15 0.00097
GO:0016740 transferase activity 203 58 0.00098
GO:0031625 ubiquitin protein ligase binding 30 14 0.00105
GO:0001664 G-protein-coupled receptor binding 47 19 0.00119
GO:0005515 protein binding 593 133 0.00123
GO:0004697 protein kinase C activity 4 4 0.00182
GO:0008603 cAMP-dependent protein kinase regulator
activity
4 4 0.00182
GO:0048407 platelet-derived growth factor binding 4 4 0.00182
GO:0046332 SMAD binding 19 10 0.00188
GO:0030674 protein binding, bridging 9 6 0.00359
GO:0004675 transmembrane receptor protein ser-
ine/threonine kinase activity
12 7 0.0046
GO:0005024 transforming growth factor beta-activated
receptor activity
12 7 0.0046
GO:0004702 receptor signaling protein serine/threonine
kinase activity
28 12 0.00592
GO:0004712 protein serine/threonine/tyrosine kinase
activity
10 6 0.00743
GO:0030234 enzyme regulator activity 89 28 0.00764
GO:0031735 CCR10 chemokine receptor binding 3 3 0.0089
GO:0004435 phosphatidylinositol phospholipase C activ-
ity
8 5 0.01198
GO:0004629 phospholipase C activity 8 5 0.01198
GO:0017002 activin receptor activity 8 5 0.01198
GO:0070412 R-SMAD binding 8 5 0.01198
GO:0005488 binding 645 138 0.01779
GO:0019838 growth factor binding 47 16 0.02059
GO:0008047 enzyme activator activity 36 13 0.02192
Continued on next page...
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GO:0042802 identical protein binding 71 22 0.02224
GO:0004708 MAP kinase kinase activity 9 5 0.02248
GO:0005161 platelet-derived growth factor receptor
binding
9 5 0.02248
GO:0042169 SH2 domain binding 9 5 0.02248
GO:0004709 MAP kinase kinase kinase activity 12 6 0.02254
GO:0060090 binding, bridging 12 6 0.02254
GO:0005126 cytokine receptor binding 84 25 0.02514
GO:0034713 type I transforming growth factor beta re-
ceptor binding
4 3 0.03014
GO:0035254 glutamate receptor binding 4 3 0.03014
GO:0043621 protein self-association 4 3 0.03014
GO:0000975 regulatory region DNA binding 30 11 0.03071
GO:0001067 regulatory region nucleic acid binding 30 11 0.03071
GO:0044212 transcription regulatory region DNA bind-
ing
30 11 0.03071
GO:0005096 GTPase activator activity 10 5 0.03752
GO:0008081 phosphoric diester hydrolase activity 10 5 0.03752
GO:0043028 caspase regulator activity 10 5 0.03752
GO:0004716 receptor signaling protein tyrosine kinase
activity
7 4 0.0376
GO:0005160 transforming growth factor beta receptor
binding
7 4 0.0376
GO:0031434 mitogen-activated protein kinase kinase
binding
7 4 0.0376
GO:0048185 activin binding 7 4 0.0376
GO:0003682 chromatin binding 20 8 0.03789
GO:0004706 JUN kinase kinase kinase activity 2 2 0.04321
GO:0005017 platelet-derived growth factor-activated re-
ceptor activity
2 2 0.04321
GO:0008093 cytoskeletal adaptor activity 2 2 0.04321
GO:0030159 receptor signaling complex scaffold activity 2 2 0.04321
GO:0030617 transforming growth factor beta receptor,
inhibitory cytoplasmic mediator activity
2 2 0.04321
GO:0031730 CCR5 chemokine receptor binding 2 2 0.04321
GO:0031732 CCR7 chemokine receptor binding 2 2 0.04321
GO:0034711 inhibin binding 2 2 0.04321
GO:0048186 inhibin beta-A binding 2 2 0.04321
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GO:0048187 inhibin beta-B binding 2 2 0.04321
GO:0070491 repressing transcription factor binding 2 2 0.04321
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Table B.2: Significant Gene Ontology enrichments of genes in the predicted inhibi-
tion interactions.
GO.ID Term Annotated Significant P-value
GO:0051219 phosphoprotein binding 15 8 5.60E-06
GO:0045309 protein phosphorylated amino acid binding 9 6 1.70E-05
GO:0001784 phosphotyrosine binding 7 5 6.10E-05
GO:0004707 MAP kinase activity 8 5 0.00015
GO:0019901 protein kinase binding 80 16 0.0003
GO:0004016 adenylate cyclase activity 9 5 0.00032
GO:0009975 cyclase activity 9 5 0.00032
GO:0016849 phosphorus-oxygen lyase activity 9 5 0.00032
GO:0002020 protease binding 6 4 0.00057
GO:0019900 kinase binding 89 16 0.00111
GO:0016829 lyase activity 12 5 0.00167
GO:0008022 protein C-terminus binding 19 6 0.00292
GO:0003824 catalytic activity 337 38 0.00344
GO:0019899 enzyme binding 147 21 0.00373
GO:0030674 protein binding, bridging 9 4 0.00394
GO:0042169 SH2 domain binding 9 4 0.00394
GO:0003924 GTPase activity 27 7 0.00446
GO:0004723 calcium-dependent protein serine/threo-
nine phosphatase activity
2 2 0.00679
GO:0043559 insulin binding 2 2 0.00679
GO:0008294 calcium- and calmodulin-responsive adeny-
late cyclase activity
6 3 0.00908
GO:0005057 receptor signaling protein activity 46 9 0.00949
GO:0016462 pyrophosphatase activity 39 8 0.01091
GO:0016817 hydrolase activity, acting on acid anhy-
drides
39 8 0.01091
GO:0016818 hydrolase activity, acting on acid an-
hydrides, in phosphorus-containing anhy-
drides
39 8 0.01091
GO:0017111 nucleoside-triphosphatase activity 39 8 0.01091
GO:0060090 binding, bridging 12 4 0.0128
GO:0046934 phosphatidylinositol-4,5-bisphosphate
3-kinase activity
7 3 0.01496
GO:0019902 phosphatase binding 19 5 0.01557
GO:0035014 phosphatidylinositol 3-kinase regulator ac-
tivity
3 2 0.01927
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GO:0004702 receptor signaling protein serine/threonine
kinase activity
28 6 0.02239
GO:0004693 cyclin-dependent protein kinase activity 8 3 0.02254
GO:0043548 phosphatidylinositol 3-kinase binding 8 3 0.02254
GO:0016787 hydrolase activity 112 15 0.03029
GO:0004428 inositol or phosphatidylinositol kinase ac-
tivity
9 3 0.03184
GO:0005158 insulin receptor binding 9 3 0.03184
GO:0035004 phosphatidylinositol 3-kinase activity 9 3 0.03184
GO:0035591 signaling adaptor activity 9 3 0.03184
GO:0035639 purine ribonucleoside triphosphate binding 197 23 0.03188
GO:0032403 protein complex binding 39 7 0.03489
GO:0017046 peptide hormone binding 4 2 0.03649
GO:0051059 NF-kappaB binding 4 2 0.03649
GO:0004722 protein serine/threonine phosphatase activ-
ity
10 3 0.04285
GO:0005159 insulin-like growth factor receptor binding 10 3 0.04285
GO:0047485 protein N-terminus binding 10 3 0.04285
GO:0019903 protein phosphatase binding 17 4 0.04493
GO:0017076 purine nucleotide binding 203 23 0.04503
GO:0032553 ribonucleotide binding 203 23 0.04503
GO:0032555 purine ribonucleotide binding 203 23 0.04503
GO:0005524 ATP binding 182 21 0.04778
GO:0016301 kinase activity 193 22 0.04781
GO:0019904 protein domain specific binding 60 9 0.04999
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